var title_f17_4_17472="Anechoic and complex pleural effusions";
var content_f17_4_17472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/PULM/52741/Anechoic_complex_eff_conv.mp4?title=Anechoic+and+complex+pleural+effusions\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anechoic and complex pleural effusions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17472=[""].join("\n");
var outline_f17_4_17472=null;
var title_f17_4_17473="Feeding jejunostomy";
var content_f17_4_17473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Feeding jejunostomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 629px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A jejunal feeding tube is placed approximately 20 cm distal to the Roux-en-Y entero-enterostomy, with a Stamm type jejunostomy, secured with a double purse-string suture of 3-0 absorbable suture and then anchored to the anterior abdominal wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17473=[""].join("\n");
var outline_f17_4_17473=null;
var title_f17_4_17474="Correct placement of Hulka clip";
var content_f17_4_17474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Correct placement of spring-loaded clip for sterilization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 367px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17474=[""].join("\n");
var outline_f17_4_17474=null;
var title_f17_4_17475="Mechanism of a clenched fist injury";
var content_f17_4_17475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Mechanism of a clenched fist injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fight bite injuries to the hand usually occur with the fist in a clenched position. When the fist makes contact with a victim's mouth, the teeth can easily penetrate the skin and extensor tendon that are stretched tightly over the metacarpal head, thus injuring the underlying bone and joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17475=[""].join("\n");
var outline_f17_4_17475=null;
var title_f17_4_17476="Methohexital: Patient drug information";
var content_f17_4_17476=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methohexital: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/15/24823?source=see_link\">",
"     see \"Methohexital: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/20/40262?source=see_link\">",
"     see \"Methohexital: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F194470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Brevital&reg; Sodium",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F194471\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Brevital&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10016483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be watched closely by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put you to sleep for surgery.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give this drug to an infant younger than 1 month of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702497",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methohexital or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703810",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have porphyria.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697168",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have anemia, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698063",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698131",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hiccups.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11337 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-77399545CD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17476=[""].join("\n");
var outline_f17_4_17476=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194470\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194471\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016483\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016485\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016484\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016488\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016489\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016491\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016487\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016492\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016493\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/15/24823?source=related_link\">",
"      Methohexital: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/20/40262?source=related_link\">",
"      Methohexital: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_4_17477="Proximal type I endoleak";
var content_f17_4_17477=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F79443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F79443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Proximal type I endoleak",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Aortogram showing an infrarenal abdominal aortic aneurysm with a severely angulated aortic neck.",
"    <br>",
"     (B) After endograft placement, a&nbsp;type Ia endoleak&nbsp;is seen laterally on the right on the completion aortogram. The endoleak persists in spite of&nbsp;balloon angioplasty.",
"     <br>",
"      (C) The endoleak has resolved with the placement of a proximal aortic cuff.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17477=[""].join("\n");
var outline_f17_4_17477=null;
var title_f17_4_17478="Hepatitis C";
var content_f17_4_17478=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Hepatitis C (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/4/17478/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17478/contributors\" id=\"au4715\">",
"       Peter A L Bonis, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17478/contributors\" id=\"au6409\">",
"       Sanjiv Chopra, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/4/17478/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17478/contributors\" id=\"se6915\">",
"       Adrian M Di Bisceglie, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/4/17478/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17478/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?17/4/17478?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     The term \"hepatitis\" is used to describe a common form of liver injury. Hepatitis simply means \"inflammation of the liver\" (the suffix \"itis\" means inflammation, and \"hepa\" means liver). Hepatitis has a number of causes, including alcohol abuse, large doses of certain medicines, poisonous mushrooms, and viruses.",
"    </p>",
"    <p>",
"     Hepatitis C is caused by a virus that is spread from one person to another in blood and body fluids, such as by sharing IV drug needles, or \"works\", or during pregnancy and delivery. Chronic hepatitis C is the most common chronic liver disease and causes 8000 to 13,000 deaths each year among people who have developed advanced cirrhosis and complications related to cirrhosis. The majority of liver transplants performed in the United States are done for people with chronic hepatitis C.",
"    </p>",
"    <p>",
"     This article discusses the symptoms, causes, and long-term management of hepatitis C virus (HCV). Articles about hepatitis A and B are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/61/22483?source=see_link\">",
"      \"Patient information: Hepatitis A (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      \"Patient information: Hepatitis B (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HEPATITIS C SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     When you are first exposed to the hepatitis C virus and become infected, you have \"acute hepatitis C\". Most people have no symptoms of infection during this time.",
"    </p>",
"    <p>",
"     In 70 to 80 percent of people, the infection becomes chronic. The word \"chronic\" implies that the infection will be prolonged, or even lifelong, unless you get treatment that cures the infection.",
"    </p>",
"    <p>",
"     Many people with chronic hepatitis C have no symptoms, even if there is serious liver damage. Of those who do develop symptoms, the most common symptom is fatigue; other less common symptoms include nausea, lack of appetite, muscle or joint aches, weakness, and weight loss.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HOW DID I BECOME INFECTED WITH HEPATITIS C?",
"     </span>",
"    </p>",
"    <p>",
"     The hepatitis C virus is spread by contact with blood.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Blood and blood products",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hepatitis C was commonly spread by contaminated blood transfusions until the early 1990s, when a blood test was developed to screen blood donors for hepatitis C. As a result, the current risk of becoming infected with hepatitis C from a blood transfusion is quite small, estimated at 1 in 1.9 million. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"      \"Patient information: Blood donation and transfusion (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Sex",
"     </span>",
"     &nbsp;&mdash;&nbsp;The hepatitis C virus can be spread through sex, although the risk is much smaller than with other types of viruses. The risk of transmission between",
"     <strong>",
"      stable monogamous",
"     </strong>",
"     sexual partners (ie, between sexual partners who have no other sexual contacts) is estimated to be approximately 1 in 1000 per year. Because of this small risk, most experts do not feel that use of condoms is necessary to prevent transmission of hepatitis C in monogamous couples.",
"    </p>",
"    <p>",
"     However, if you do NOT have a stable monogamous sexual partner, you SHOULD use condoms. This is to protect you from new infections (such as HIV or other sexually transmitted diseases), as well as to protect your partner from acquiring hepatitis C.",
"    </p>",
"    <p>",
"     The risk of transmitting the virus is higher in people who are infected with both hepatitis C and HIV. Condoms are recommended during sex for all people who have HIV.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Other transmission",
"     </span>",
"     &nbsp;&mdash;&nbsp;There is no evidence that kissing; hugging; sneezing; coughing; casual contact; sharing food, water, eating utensils, or drinking glasses; or having other contact without blood exposure can spread the hepatitis C virus.",
"    </p>",
"    <p>",
"     However, sharing toothbrushes, razors, and other objects that might be contaminated with blood is",
"     <strong>",
"      not",
"     </strong>",
"     recommended. This also applies to implements (such as straws) used to inhale cocaine and needles and syringes used to inject drugs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The risk of transmitting hepatitis C to your baby during pregnancy probably depends on the level of virus in your bloodstream. In general, the risk is about 5 to 6 percent (about 1 in 20) but is increased in people who are also infected with HIV, in whom the risk increases to 12 percent, or one in eight.",
"    </p>",
"    <p>",
"     Women with hepatitis C who are pregnant or thinking about getting pregnant should speak to their doctor about these risks. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=see_link\">",
"      \"Vertical transmission of hepatitis C virus\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"      \"Pregnancy in women with pre-existing chronic liver disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      HEPATITIS C DIAGNOSIS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Blood tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hepatitis C is diagnosed with a blood test. In most cases, a screening blood test (hepatitis C virus antibody) is done because you have one or more risk factors for the infection, including the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Recent exposure to blood infected with HCV (eg, an accidental needle stick)",
"      </li>",
"      <li>",
"       Being HIV positive",
"      </li>",
"      <li>",
"       Past or current sexual partner of a person with HCV",
"      </li>",
"      <li>",
"       Previous or current use of IV drugs",
"      </li>",
"      <li>",
"       Previous or current use of hemodialysis (a treatment for kidney failure)",
"      </li>",
"      <li>",
"       Recipient of donated blood or organs before July 1992 or blood clotting factors before 1987",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Less commonly, a screening test will be done because you have symptoms of recent hepatitis infection, such as a lack of appetite, nausea, flu-like symptoms, yellow discoloration of the skin (jaundice), or pain under the ribs on the right side (where the liver is located) (",
"     <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     If the screening test is positive for hepatitis C, further testing is performed to confirm that the virus is present. Results of these tests are used to guide treatment:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hepatitis C virus (HCV) RNA is a measure of the amount of virus circulating in the blood. HCV RNA is detectable in the blood within days to eight weeks following exposure.",
"      </li>",
"      <li>",
"       Hepatitis C genotype testing determines the specific type of HCV; most people in the United States have type 1, but types 2 and 3 are also common. Type 4 is sometimes seen but is uncommon.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Liver biopsy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Liver biopsy is done as an outpatient procedure and involves taking a tiny sample of the liver tissue and looking at it under a microscope. This procedure is described in detail in a separate article. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=see_link\">",
"      \"Patient information: Liver biopsy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     A liver biopsy is not required to diagnose hepatitis C. However, a liver biopsy is often performed if your doctor is planning to start hepatitis C treatment. Results of the biopsy can help to determine how much the disease has advanced and the long-term prognosis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      HEPATITIS C COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     The hepatitis C virus causes damage to the liver, although the liver is able to repair itself to some degree. This damage occurs over many years.",
"    </p>",
"    <p>",
"     In some people, scar tissue (called fibrosis) accumulates in the liver and can eventually become extensive, leading to cirrhosis. People with cirrhosis have a severely scarred liver and are at increased risk for serious complications. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=see_link\">",
"      \"Patient information: Cirrhosis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     One of the most feared complications of cirrhosis is the development of liver cancer (called hepatocellular carcinoma). About 2 percent of people with cirrhosis (1 in 50) develop hepatocellular carcinoma each year. Therefore, the majority of people with cirrhosis due to hepatitis C will",
"     <strong>",
"      not",
"     </strong>",
"     develop hepatocellular carcinoma.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Risk factors for complications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Researchers have studied large groups of people with hepatitis C to find out what happens to them over time. Only about 20 percent (or one in five) will develop cirrhosis within 20 years of becoming infected with hepatitis C. Most others will have some inflammation in the liver but will not have significant scarring.",
"    </p>",
"    <p>",
"     Researchers have tried to identify factors that increase the risk of developing cirrhosis after infection with hepatitis C. The most important include:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Drinking alcohol",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with hepatitis C who drink alcohol are at a much greater risk for developing cirrhosis. The amount of alcohol that is safe to consume is not well established for people with hepatitis C. Even small amounts (social drinking) have been linked to an increased risk of cirrhosis in people with hepatitis C. Until more is known, we recommend completely avoiding alcohol.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H347504\">",
"     <span class=\"h3\">",
"      Marijuana use",
"     </span>",
"     &nbsp;&mdash;&nbsp;Using marijuana can lead to faster scarring of the liver in some people, and people with hepatitis C should not use marijuana.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H347512\">",
"     <span class=\"h3\">",
"      Obesity",
"     </span>",
"     &nbsp;&mdash;&nbsp;Obesity can lead to the deposition of fat in the liver (steatosis), which increases the risk of developing cirrhosis. Fat in the liver may also make some treatments for hepatitis C less effective.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Amount of liver damage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Increasing amounts of inflammation in the liver make it more likely that the liver will become scarred. There are many tools for determining how much damage hepatitis C has caused, including blood tests, an ultrasound of the liver, and liver biopsy. Liver biopsy is the \"gold standard\" test, although it is not recommended in everyone. (See",
"     <a class=\"local\" href=\"#H10\">",
"      'Liver biopsy'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      HEPATITIS C TREATMENT OPTIONS",
"     </span>",
"    </p>",
"    <p>",
"     The goal of hepatitis C treatment is to prevent worsening of liver disease and to get rid of the virus. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=see_link\">",
"      \"Overview of the management of chronic hepatitis C virus infection\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Pegylated interferon (peginterferon) and ribavirin",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common treatment for hepatitis C is a combination of two medicines, pegylated interferon (also called peginterferon) and ribavirin. The ribavirin treatment is taken as a pill, and the pegylated interferon is taken as a weekly shot. The recommended duration of treatment with this combination is usually 24 weeks for genotypes 2 and 3. In the past, patients with genotype 1 were all treated for 48 weeks. However, treatment for patients with genotype 1 now includes an additional medication that improves cure rates, and the length of treatment depends upon whether a person has been treated in the past and upon changes in the level of the virus in the blood during treatment. (See",
"     <a class=\"local\" href=\"#H687780731\">",
"      'Protease inhibitors'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     During treatment, you will have tests to monitor the level of the virus in your blood (called the viral load). The goal of treatment is to completely get rid of the virus. Treatment may be stopped early if the virus does not respond or if you have intolerable treatment-related side effects.",
"    </p>",
"    <p>",
"     Side effects occur in almost 80 percent of patients who are given pegylated interferon and ribavirin. The most common side effects include flu-like symptoms, low levels of red and white blood cells, depression, and fatigue. Treatments to minimize these symptoms are available.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H687780731\">",
"     <span class=\"h2\">",
"      Protease inhibitors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients with genotype 1 are also treated with a protease inhibitor in addition to pegylated interferon and ribavirin. Protease inhibitors became available in May 2011, so patients treated before to this time did not receive them.",
"    </p>",
"    <p>",
"     Protease inhibitors do not work if taken by themselves because the virus quickly becomes resistant. By taking the protease inhibitors with peginterferon and ribavirin, resistance is much less likely. Protease inhibitors are pills and include boceprevir (brand name: Victrelis",
"     <sup>",
"      TM",
"     </sup>",
"     ) and telaprevir (brand name: Incivek",
"     <sup>",
"      TM",
"     </sup>",
"     ). These medications are used only for patients with genotype 1 and significantly increase cure rates in patients with genotype 1.",
"    </p>",
"    <p>",
"     Common side effects of protease inhibitors include low blood counts (anemia) and rashes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Should I be treated?",
"     </span>",
"     &nbsp;&mdash;&nbsp;The decision to have treatment for chronic hepatitis C infection is based upon a number of factors, some of which are discussed below. Treatment for hepatitis C is not recommended for everyone; you and your doctor should discuss the potential risks and benefits of treatment before you begin.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Treatment with peginterferon is not recommended for people whose depression is not well controlled. People with uncontrolled depression are at risk for committing suicide during treatment. Interferon can be used in people with well-controlled depression.",
"      </li>",
"      <li>",
"       Ribavirin should",
"       <strong>",
"        not",
"       </strong>",
"       be used by women who are pregnant, thinking about getting pregnant, or unable to use a reliable form of birth control, because it can cause severe birth defects. In addition, protease inhibitors (boceprevir and telaprevir) decrease how well birth control pills work, so women who are also taking a protease inhibitor need to use a second reliable form of birth control. Likewise, ribavirin should not be used by men whose partners are trying to become pregnant or men who are not using a reliable form of birth control. Ribavirin can damage the sperm of men who use the drug and can lead to birth defects, even if the father is the only parent taking the drug. Also, women and men should continue to use a reliable form of birth control for six months after stopping ribavirin.",
"      </li>",
"      <li>",
"       People with underlying autoimmune disorders (eg, lupus, rheumatoid arthritis) might have an increased risk of treatment-related complications related to peginterferon.",
"      </li>",
"      <li>",
"       Certain groups of people develop liver scarring at a slow rate. In this group, it is reasonable to delay treatment until fibrosis progresses, liver function test results become abnormal, or clinical trials prove that earlier treatment is beneficial. This group includes people who:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Have normal liver function test results (ALT)",
"      </li>",
"      <li>",
"       Were infected with hepatitis C before age 35 years",
"      </li>",
"      <li>",
"       Are female",
"      </li>",
"      <li>",
"       Do not drink alcohol",
"      </li>",
"      <li>",
"       Have no or minimal scarring on liver biopsy",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Cure",
"     </span>",
"     &nbsp;&mdash;&nbsp;The chance of being cured of hepatitis C depends in part on the type of hepatitis C virus (ie, the genotype). Overall, the chance is approximately 70 to 80 percent for people with genotype 1 who take all three drugs (peginterferon, ribavirin, and a protease inhibitor), and 80 percent or more with genotypes 2 and 3. The chance of cure is 50 to 70 percent for genotype 4.",
"    </p>",
"    <p>",
"     To determine if you are cured, you must wait six months after finishing treatment. Cure is defined as having no detectable levels of the virus for more than six months after stopping treatment. Follow-up studies of these people have shown no trace of the virus in the blood or liver for over 10 years.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      If hepatitis C does not respond or comes back",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are several options for people whose viral levels do not drop or whose infection comes back after the first round of treatment. The best option depends upon what medicines you took before, how well you tolerated the previous treatment, your current liver function, and other factors.",
"    </p>",
"    <p>",
"     Options include watching and waiting, trying a different treatment regimen, or enrolling in a clinical trial. (See",
"     <a class=\"local\" href=\"#H28\">",
"      'Clinical trials'",
"     </a>",
"     below.) Discuss your options with a doctor who specializes in liver diseases (a hepatologist) or infectious diseases.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      LONG-TERM MANAGEMENT OF HEPATITIS C",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Screening tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have hepatitis C and cirrhosis, you should have screening tests for liver cancer. These tests usually include an ultrasound of the liver twice a year. Some doctors also check a blood test (to measure a protein called alpha fetoprotein level).",
"    </p>",
"    <p>",
"     In addition, a procedure called an upper endoscopy might be done to look for esophageal varices (enlarged veins in the esophagus). Varices develop in roughly 50 percent of people with cirrhosis. Upper endoscopy uses a thin, flexible fiberoptic instrument to inspect the esophagus (food pipe) and stomach. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/9/12434?source=see_link\">",
"      \"Patient information: Screening for esophageal varices (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Diet",
"     </span>",
"     &nbsp;&mdash;&nbsp;No specific diet improves signs or symptoms of hepatitis C. The best advice is to eat a normal, healthy, and balanced diet. It is reasonable to take a multivitamin without iron. It is safe to drink coffee; in fact, some studies suggest that coffee is good for the liver. Drinking alcohol is strongly discouraged to protect the liver from further damage.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Vaccines",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Anyone who is infected with hepatitis C should be vaccinated against hepatitis A and B, unless he or she is already immune. A blood test can tell if you are immune.",
"      </li>",
"      <li>",
"       A vaccine that helps to prevent pneumonia is recommended. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=see_link\">",
"        \"Patient information: Pneumonia prevention (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Influenza (flu) vaccination is recommended every year, usually in the fall. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?38/12/39105?source=see_link\">",
"        \"Patient information: Influenza prevention (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Routine vaccines are also recommended, including diphtheria and tetanus booster every 10 years. Read more about adult vaccines separately. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"        \"Patient information: Adult vaccines (Beyond the Basics)\"",
"       </a>",
"       and",
"       <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8569?source=see_link\">",
"        \"Immunizations for patients with chronic liver disease\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Exercise is good for overall health and is encouraged, but it has no effect on hepatitis C virus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Prescription and nonprescription medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;The liver breaks down many medicines, including prescription and nonprescription medicines, supplements, and herbs. Thus, it is always best to check with your doctor or pharmacist before starting a new medicine. Most medicines are safe for people with hepatitis C, unless the liver is scarred.",
"    </p>",
"    <p>",
"     One important exception is acetaminophen (Tylenol&reg;); the maximum recommended dose is 500 milligrams every six hours. Some medicines, such as cold medicines, may contain acetaminophen, so it is important to always check ingredient labels.",
"    </p>",
"    <p>",
"     You should completely avoid ibuprofen (sold as Advil&reg;, Motrin&reg;, and store brands), naproxen (sold as Aleve&reg; and store brands), and aspirin (sold as Bufferin&reg;, Excedrin&reg;, and store brands).",
"    </p>",
"    <p>",
"     Daily use of marijuana has been associated with worsening liver disease and is not recommended, particularly for people with hepatitis C.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Herbal medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many herbal products claim to \"cure\" or improve hepatitis C; none of these claims has been proven true. In addition, some herbal medicines can seriously injure the liver.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      Support",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sharing your concerns with others who have the same diagnosis can help you learn to live with hepatitis C. The American Liver Foundation has helpful advice and a list of support groups (",
"     <a class=\"external\" href=\"file://www.liverfoundation.org/\">",
"      www.liverfoundation.org",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     If you have recently discovered that you or someone you care about has hepatitis C, there are many reasons to be optimistic:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hepatitis C progresses slowly, and many people who are infected will never get sick.",
"      </li>",
"      <li>",
"       You are not alone; about 2.7 million people in the United States have hepatitis C. Treatment is available, and researchers are constantly working to develop new and better therapies.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      CLINICAL TRIALS",
"     </span>",
"    </p>",
"    <p>",
"     Even though combination therapy with peginterferon plus ribavirin (and protease inhibitors in people with genotype 1) cures up to 80 percent of people with hepatitis C, some are not cured. Thus, new treatments for hepatitis C are actively being developed.",
"    </p>",
"    <p>",
"     A clinical trial is a carefully controlled way to study how well new treatments or new combinations of known therapies work. Ask for more information about clinical trials or read about clinical trials at",
"     <a class=\"external\" href=\"file://clinicaltrials.gov/\">",
"      file://clinicaltrials.gov/",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H109188603\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H109188610\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/39/32370?source=see_link\">",
"      Patient information: Hepatitis C (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/22/4451?source=see_link\">",
"      Patient information: Latest medicines for hepatitis C (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/45/1746?source=see_link\">",
"      Patient information: Vaccines when you have hepatitis C (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/25/24979?source=see_link\">",
"      Patient information: Cirrhosis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/31/18931?source=see_link\">",
"      Patient information: Blood or body fluid exposure (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/35/30258?source=see_link\">",
"      Patient information: Treatment for hepatitis C (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=see_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H109188627\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/61/22483?source=see_link\">",
"      Patient information: Hepatitis A (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"      Patient information: Blood donation and transfusion (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=see_link\">",
"      Patient information: Liver biopsy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=see_link\">",
"      Patient information: Cirrhosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/9/12434?source=see_link\">",
"      Patient information: Screening for esophageal varices (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=see_link\">",
"      Patient information: Pneumonia prevention (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/12/39105?source=see_link\">",
"      Patient information: Influenza prevention (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H109188700\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29780?source=see_link\">",
"      Characteristics of the hepatitis C virus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/50/31530?source=see_link\">",
"      Clinical manifestations and natural history of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=see_link\">",
"      Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/1/1048?source=see_link\">",
"      Diagnosis of hepatitis C virus infection in patients on dialysis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25194?source=see_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=see_link\">",
"      Extrahepatic manifestations of hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9496?source=see_link\">",
"      Hepatitis C and alcohol",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/56/4999?source=see_link\">",
"      Hepatitis C and transfusion: A 'lookback' primer",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31289?source=see_link\">",
"      Hepatitis C virus infection and renal transplantation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/24/31114?source=see_link\">",
"      Hepatitis C virus infection in patients on maintenance dialysis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/30/15847?source=see_link\">",
"      Approach to patients with chronic hepatitis C virus infection and normal serum aminotransferases",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38378?source=see_link\">",
"      Investigational therapies for hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16474?source=see_link\">",
"      Liver transplantation for hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/9/16538?source=see_link\">",
"      Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41337?source=see_link\">",
"      Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=see_link\">",
"      Vertical transmission of hepatitis C virus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/33/28184?source=see_link\">",
"      Mechanism of action and efficacy of ribavirin for the treatment of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/59/35768?source=see_link\">",
"      Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=see_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8569?source=see_link\">",
"      Immunizations for patients with chronic liver disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/600?source=see_link\">",
"      Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14474?source=see_link\">",
"      Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/hepatitisc.html\">",
"      www.nlm.nih.gov/medlineplus/hepatitisc.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://digestive.niddk.nih.gov/ddiseases/pubs/hepc_ez/\">",
"      file://digestive.niddk.nih.gov/ddiseases/pubs/hepc_ez/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?17/4/17478/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 24, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?17/4/17478?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17478/abstract/1\">",
"      Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17478/abstract/2\">",
"      Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002; 36:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17478/abstract/3\">",
"      Dienstag JL, McHutchison JG. American Gastroenterological Association medical position statement on the management of hepatitis C. Gastroenterology 2006; 130:225.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f17_4_17478=[""].join("\n");
var outline_f17_4_17478=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HEPATITIS C SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HOW DID I BECOME INFECTED WITH HEPATITIS C?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           HEPATITIS C DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           HEPATITIS C COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           HEPATITIS C TREATMENT OPTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           LONG-TERM MANAGEMENT OF HEPATITIS C",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           CLINICAL TRIALS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\" title=\"figure 1\">",
"           Abdomen anatomy adult PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f17_4_17479="Precorneal tear film";
var content_f17_4_17479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Precorneal tear film",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 675px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Pflugfelder, SC, Solomon, A, Stern, ME. The Diagnosis and Management of Dry Eye: A Twenty-Five Year Review. Cornea 2000; 19:644.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17479=[""].join("\n");
var outline_f17_4_17479=null;
var title_f17_4_17480="Surgical management of mitral stenosis";
var content_f17_4_17480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of mitral stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Matthew J Sorrentino, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Gabriel S Aldea, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Edward Verrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17480/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/4/17480/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral stenosis (MS) is a disabling and eventually lethal disease unless treated with valvotomy or valve replacement. Almost all cases are due to rheumatic heart disease with symptoms usually appearing 16 to 40 years after the episode of acute rheumatic fever. Variants of mitral stenosis are seen in children born with congenital heart defects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=see_link\">",
"     \"Natural history of mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If untreated, MS often progresses to significant symptoms (eg, dyspnea and fatigue) and serious complications (eg, pulmonary edema, systemic arterial embolism, pulmonary hypertension, and death). Medical therapy can relieve symptoms but does not affect the obstruction to flow. Among patients with severe symptomatic MS, numerous studies have demonstrated a significant reduction in mortality with surgery compared to medical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link\">",
"     \"Medical management and indications for intervention in mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical approaches include closed commissurotomy, open commissurotomy, mitral valve repair, and mitral valve replacement. When correction of MS is indicated, the question remains which surgical option, if any, is most appropriate for a given patient, especially in light of the success achieved with percutaneous mitral balloon valvotomy (PMBV).",
"   </p>",
"   <p>",
"    The efficacy of the different surgical techniques, including comparison with PMBV, and the management of patients with MS undergoing noncardiac surgery will be reviewed here. Issues directly related to the timing of intervention, percutaneous mitral balloon valvotomy (PMBV) and to the medical management of MS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link\">",
"     \"Medical management and indications for intervention in mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CHOICE OF PROCEDURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Rheumatic MS",
"    </span>",
"    &nbsp;&mdash;&nbsp;When intervention is warranted in patients with rheumatic MS, the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommend that PMBV is preferred to surgery if the valve morphology is favorable and the patient does not have left atrial thrombus or moderate to severe (3+ to 4+) mitral regurgitation (",
"    <a class=\"graphic graphic_algorithm graphicRef55549 graphicRef68528 \" href=\"UTD.htm?2/53/2897\">",
"     algorithm 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef79292 graphicRef57298 \" href=\"UTD.htm?24/6/24674\">",
"     algorithm 2A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef70612 \" href=\"UTD.htm?20/38/21103\">",
"     algorithm 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef58960 \" href=\"UTD.htm?30/22/31084\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]. The data supporting this conclusion are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H21#H21\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'PMBV versus surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, even with unfavorable anatomy, PMBV may be performed as a palliative procedure if the patient is deemed to be at high risk for surgery and there is no left atrial thrombus or moderate to severe mitral regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H2#H2\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Choice of PMBV'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended surgery only when one or more of the following is present (",
"    <a class=\"graphic graphic_table graphicRef76806 \" href=\"UTD.htm?27/32/28172\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      PMBV is not available",
"     </li>",
"     <li>",
"      There is left atrial thrombus that persists despite anticoagulation",
"     </li>",
"     <li>",
"      The mitral valve is nonpliable or severely calcified",
"     </li>",
"     <li>",
"      Moderate to severe coexisting mitral regurgitation is present",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among patients with unfavorable valve morphology who are referred for mitral valve surgery, valve repair is performed if possible. The repair may include both open commissurotomy and placement of an annuloplasty ring after direct visualization of the valve [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mitral valve replacement is generally considered the last alternative for the treatment of MS because of its higher perioperative mortality and potential for morbidity. However, in symptomatic patients with severe MS in whom neither PMBV nor surgical valve repair is possible, valve replacement results in marked symptomatic improvement and is associated with improved long-term survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Congenital MS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is usually preferred in patients with congenital MS, since the anatomy is complex, the utility of PMBV may be limited, and catheterization procedures are potentially dangerous [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H4#H4\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Congenital MS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines reached the following conclusions with respect to mitral valve surgery in adolescents or young adults with congenital MS [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgery is indicated in patients with New York Heart Association (NYHA) class III or IV symptoms (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 3",
"      </a>",
"      ) and, on Doppler echocardiography, a mean mitral valve gradient greater than 10 mmHg.",
"     </li>",
"     <li>",
"      Surgery is reasonable (a weaker recommendation) in two settings: in patients with mild (NYHA class II), (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 3",
"      </a>",
"      ) symptoms and, on Doppler echocardiography, a mean mitral valve gradient greater than 10 mmHg; and in asymptomatic patients with a pulmonary artery systolic pressure &ge;50 mmHg and, on Doppler echocardiography, a mean mitral valve gradient &ge;10 mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The efficacy of surgery was considered not well established in asymptomatic patients who had new onset atrial fibrillation (AF) or multiple systemic emboli despite adequate antithrombotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17674209\">",
"    <span class=\"h2\">",
"     Mitral annular calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe MAC rarely causes symptomatic severe calcific mitral stenosis. In these patients, only surgical intervention can relieve the obstruction since percutaneous mitral valve balloon valvuloplasty (which treats commissural fusion in patients with rheumatic valve disease) is not effective to treat MAC. However, the presence of severe MAC complicates mitral valve surgery and is associated with high operative mortality rates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/58/37801?source=see_link&amp;anchor=H36#H36\">",
"     \"Mitral annular calcification\", section on 'Mitral valve surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Repeat intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;PMBV and surgical commissurotomy can be repeated as long as the valve morphology remains favorable. The approximate frequency of repeat intervention is 7 to 10 percent at seven years with both procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/5\">",
"     5",
"    </a>",
"    ]. The outcome after repeat intervention may be less favorable than with the initial procedure because there is usually more valve deformity, calcification, and fibrosis.",
"   </p>",
"   <p>",
"    Repeat PMBV carries no greater risk than the initial procedure; in contrast, repeat surgical commissurotomy has a mortality rate 2 to 10 times higher than that associated with the first operation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/6\">",
"     6",
"    </a>",
"    ]. Thus, despite the equivalent success with open surgical commissurotomy and PMBV [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/5\">",
"     5",
"    </a>",
"    ], these concerns provide additional support for PMBV being the intervention of choice whenever technically feasible. Furthermore, PMBV can be performed for restenosis after initial surgical commissurotomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H19#H19\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Repeat PMBV'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H20#H20\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Restenosis after surgical commissurotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CORONARY ANGIOGRAPHY PRIOR TO SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with mitral stenosis also have coronary heart disease and may require coronary intervention in addition to mitral valve surgery. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on the management of patients with valvular heart disease included general recommendations for the use of cardiac catheterization and coronary angiography to establish the presence of coronary heart disease (",
"    <a class=\"graphic graphic_table graphicRef66360 \" href=\"UTD.htm?29/4/29772\">",
"     table 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There were two main indications for coronary angiography prior to mitral valve surgery:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with chest pain, other objective evidence of ischemia, or a history of coronary disease.",
"     </li>",
"     <li>",
"      In patients at risk for coronary disease, which was defined as men &ge;35 years of age, premenopausal women &ge;35 years of age who have coronary risk factors, and postmenopausal women. In contrast, coronary angiography is not required solely for coronary risk factors in patients undergoing PMBV.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLOSED COMMISSUROTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The earliest surgical procedures for the treatment of MS were variations of closed commissurotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/7\">",
"     7",
"    </a>",
"    ]. This operation is performed on a beating heart, which is generally exposed via a left thoracotomy incision. The surgeon then uses either a transatrial or transventricular approach to introduce a dilator across the mitral valve [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/8\">",
"     8",
"    </a>",
"    ]. An obvious limitation compared to other surgical approaches is the inability to directly visualize the mitral valve.",
"   </p>",
"   <p>",
"    Success of closed commissurotomy depends upon a favorable valve morphology. As a result, only patients with pliable mitral valve leaflets, minimal calcification, and lack of significant subvalvular involvement historically were candidates for this procedure. Absolute contraindications included the presence of an atrial thrombus or moderate to severe mitral regurgitation, which can worsen upon commissural splitting.",
"   </p>",
"   <p>",
"    The safety, efficacy, and long-term results of closed commissurotomy were determined in a report from India of 3724 consecutive patients, almost one-half of whom were NYHA class IV at entry [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/9\">",
"     9",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The in-hospital mortality was 1.5 percent, and severe mitral regurgitation requiring immediate valve replacement developed in 0.3 percent.",
"     </li>",
"     <li>",
"      Mitral restenosis was noted after the fifth year of follow-up and varied from 4.2 to 11.4 per 1000 patients per year between the fifth and fifteenth year after surgery.",
"     </li>",
"     <li>",
"      Actuarial survival was 84 percent at 24 years; in addition, 86 percent of survivors at 15 years continued to have symptomatic improvement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed commissurotomy is associated with worse long-term outcomes compared to PMBV and is now rarely performed in developed countries [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/5\">",
"     5",
"    </a>",
"    ]. It is still performed in some developing nations where cost and perhaps lack of balloon valvotomy capability are continuing problems [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H21#H21\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'PMBV versus surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Closed commissurotomy has also been performed successfully in pregnant women in whom correction of MS is indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/10\">",
"     10",
"    </a>",
"    ], although PMBV is preferred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29447?source=see_link\">",
"     \"Pregnancy in women with mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OPEN COMMISSUROTOMY AND VALVE REPAIR",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the advent of cardiopulmonary bypass, open surgical commissurotomy became an attractive alternative to closed commissurotomy. This procedure is performed via a median sternotomy and has the advantage of allowing the surgeon to inspect the mitral valve and subvalvular apparatus. In addition to splitting the commissures under direct vision, the valve can be repaired by debriding calcium deposits, dividing fused chordae tendineae, and splitting papillary muscles whenever appropriate. When mitral regurgitation is present, an annuloplasty ring is placed to restore valve competency.",
"   </p>",
"   <p>",
"    In addition, thrombectomy can be performed to remove a left atrial thrombus and many surgeons amputate or ligate the left atrial appendage to remove a potential source of embolism, an approach recommended by the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Valvular morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral valves that are suitable for valve repair are pliable and noncalcified, with little or no subvalvular fusion and no calcification in the commissures [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]. However, among patients with significant mitral regurgitation (3+ to 4+), open commissurotomy alone is inadequate and more complex valve repair",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    placement of an annuloplasty ring is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety and efficacy of open commissurotomy is well established. Successful commissurotomy is generally defined as mitral valve area &gt;1.5 cm2 (normal 4 to 6 cm2) and a decrease in left atrial pressure to &le;18 mmHg in the absence of complications; the most common complication is mitral regurgitation, which occurs in 2 to 10 percent of patients.",
"   </p>",
"   <p>",
"    Results from several studies have shown no residual stenosis with open commissurotomy; perioperative mortality rates are less than 1 percent and, at five to seven years, only 7 percent of patients need a reintervention [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/5,11,12\">",
"     5,11,12",
"    </a>",
"    ]. The absence of residual stenosis means the acute success rate is essentially 100 percent. However, similar to closed commissurotomy and balloon valvulotomy, success of the procedure depends upon a favorable valve morphology and the absence of moderate or severe mitral regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In clinical trials comparing open commissurotomy to PMBV in patients who are candidates for valvotomy, the outcome was as good or better after PMBV [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/5,11\">",
"     5,11",
"    </a>",
"    ]. Other advantages of PMBV are shorter hospital stay, avoidance of the morbidity of thoracotomy, and a better outcome if repeat intervention is required [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Repeat intervention'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, open commissurotomy with valve repair remains an appropriate choice in patients who are not candidates for PMBV due to valve deformity or calcification, left atrial thrombus, or significant mitral regurgitation. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Choice of procedure'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EXERCISE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients who have undergone successful surgical commissurotomy, participation in sports should, as in patients with untreated lesions, be based upon the residual severity of MS or mitral regurgitation and the possible presence of left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/13\">",
"     13",
"    </a>",
"    ]. The capacity to exercise should be evaluated with an exercise test to at least the level of anticipated activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H3#H3\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Physical activity and exercise'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the management of chronic mitral regurgitation\", section on 'Physical activity and exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     MITRAL VALVE REPLACEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with moderate to severe mitral stenosis (mitral valve area &le;1.5 cm2), NYHA class III or IV symptoms (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 3",
"    </a>",
"    ), and a valve not amenable to either PMBV or open commissurotomy, mitral valve replacement is an option that can significantly improve the natural history of MS. Patients with severe MS (mitral valve area &le;1.0 cm2) and severe pulmonary hypertension (pulmonary artery systolic pressure &gt;60 to 80 mmHg) who are asymptomatic or only mildly symptomatic (NYHA class I or II) are also considered for mitral valve replacement if they are not candidates for PMBV or open commissurotomy (",
"    <a class=\"graphic graphic_table graphicRef76806 \" href=\"UTD.htm?27/32/28172\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Despite the perioperative mortality and potential morbidity associated with mitral valve replacement, it can significantly improve symptoms by lowering left atrial and pulmonary pressures and increasing cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. Mitral valve replacement carries a favorable 80 to 85 percent survival rate at five years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40338203\">",
"    <span class=\"h2\">",
"     Left atrial appendage ligation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with open commissurotomy, many surgeons will amputate or ligate the left atrial appendage during mitral valve replacement to remove a potential source of embolism. Although this approach was recommended by the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ], there are only limited data suggesting that the risk of stroke is reduced. This issue was addressed in a report of 205 patients who underwent mitral valve replacement (83 percent rheumatic heart disease, 86 percent in AF); ligation of the LAA was performed in 58 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/16\">",
"     16",
"    </a>",
"    ]. After almost six years, the incidence of an embolic event in patients with LAA ligation was significantly lower than in those without this procedure (3 versus 17 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21686?source=see_link\">",
"     \"Nonpharmacologic therapy to prevent embolization in patients with atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27859455\">",
"    <span class=\"h2\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of atrial fibrillation, including surgical approaches to prevent recurrent atrial fibrillation, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=see_link\">",
"     \"Surgical approaches to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Perioperative mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral valve replacement carries a higher perioperative mortality than the other approaches to correct MS. The perioperative mortality varies with the patient population, ranging from less than 5 percent in young healthy individuals to approximately 10 to 20 percent in older patients with significant comorbidities and pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ] to 25 percent in patients with NYHA class IV (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The last observation indicates the risk of delaying surgery. On the other hand, early mitral valve replacement exposes the patient to a longer period of the persistent risks of valve thrombosis, systemic embolism, endocarditis, and bleeding secondary to chronic anticoagulant therapy. The risk of one of these complications is estimated to be 4 to 7 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25497?source=see_link\">",
"     \"Complications of prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preceding discussion has emphasized that a variety of factors affect the risk for in-hospital mortality after mitral valve replacement. The most effective way of stratifying operative risk is by using one of the available validated risk stratification models. As noted above, a variety of factors affect the risk of mortality after aortic valve replacement. The risk models are helpful in the evaluation and counseling of individual patients and planning perioperative care. Models have been developed to estimate risk of in-hospital mortality and complications following aortic or mitral valve surgery with or without coronary artery bypass graft surgery (CABG). These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7252?source=see_link\">",
"     \"Estimating the mortality risk of valvular surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another important factor associated with perioperative mortality after mitral valve replacement is the volume of procedures performed at the hospital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bioprosthesis versus mechanical prosthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual valve chosen for most patients with MS who require valve replacement is a mechanical prosthesis because the patients are usually relatively young (&lt;70 years old) and most require chronic anticoagulation for atrial fibrillation (the lack of requirement for anticoagulation being a relative advantage of bioprosthetic valves).",
"   </p>",
"   <p>",
"    Comparison of bioprosthetic and mechanical mitral valve protheses is further discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=see_link&amp;anchor=H17#H17\">",
"     \"Surgical procedures for severe chronic mitral regurgitation\", section on 'Mechanical versus bioprosthetic valve'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Prosthetic valve-patient mismatch",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normalization of pulmonary artery pressure is a goal of mitral valve replacement since even mild pulmonary hypertension can impair exercise capacity and may increase morbidity and mortality. However, the effective orifice area (EOA) in prosthetic valves used for mitral valve replacement is often small in relation to body size and may be associated with transvalvular pressure gradients similar to those in mild to moderate mitral stenosis.",
"   </p>",
"   <p>",
"    The frequency with which this might occur was evaluated in a review of 56 patients with normally functioning prosthetic, mostly mechanical mitral valves [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/19\">",
"     19",
"    </a>",
"    ]. A prosthetic valve-patient mismatch, defined as an EOA &le;1.2",
"    <span class=\"nowrap\">",
"     cm2/m2,",
"    </span>",
"    was present in 40 patients and pulmonary artery hypertension, defined as a pulmonary artery systolic pressure &gt;40 mmHg, was present in 30 patients. Pulmonary artery hypertension was significantly more likely in the patients with prosthetic valve-patient mismatch (68 versus 19 percent in patients without mismatch).",
"   </p>",
"   <p>",
"    Two limitations of this study are that approximately one-half of patients received a relatively small prosthesis (size 25 and 27) and no long-term data were available to determine if this degree of mild pulmonary hypertension had adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible detrimental impact of prosthetic-patient mismatch (PPM) on long-term survival was evaluated in a subsequent retrospective study of 929 patients undergoing mitral valve replacement for both regurgitation and stenosis; the patients were followed for a mean of 6.3 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/21\">",
"     21",
"    </a>",
"    ]. The indexed EOA was calculated for each patient and used to define PPM as severe when &le;0.9",
"    <span class=\"nowrap\">",
"     cm2/m2",
"    </span>",
"    (9 percent), moderate (69 percent of patients) when &gt;0.9 and &le;1.2",
"    <span class=\"nowrap\">",
"     cm2/m2,",
"    </span>",
"    and nonsignificant when",
"    <span class=\"nowrap\">",
"     &gt;1.2cm2/m2",
"    </span>",
"    (22 percent). Patients with severe PPM had 6 and 12 year survival that was significantly less than patients with moderate or nonsignificant PPM (74 versus 84 and 90 percent at six years, and 63 versus 76 and 82 percent at 12 years). On multivariate analysis, severe PPM was associated with a higher mortality (HR 3.2, 95% CI 1.5-6.8).",
"   </p>",
"   <p>",
"    There were a number of important limitations to this study [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The absence of separate results for patients with either mitral regurgitation or stenosis.",
"     </li>",
"     <li>",
"      The inclusion of patients who might have undergone mitral valve repair using current practice standards.",
"     </li>",
"     <li>",
"      The relatively high percentage of patients with PPM, despite a high use of mechanical valves, which have better hemodynamics than bioprosthetic valves.",
"     </li>",
"     <li>",
"      Patients with moderate and severe PPM had longer cardiopulmonary bypass and aortic cross-clamp times.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a result of the above considerations, the following recommendations for the selection of a bioprosthetic or mechanical mitral valve were included in the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bioprosthetic valves are recommended in patients who cannot or will not take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      or have a clear contraindication to warfarin therapy.",
"     </li>",
"     <li>",
"      Among patients who can take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , the weight of evidence supports the following approach:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A mechanical valve in patients under age 65 who have long-standing AF.",
"     </li>",
"     <li>",
"      A bioprosthetic valve in patients &ge;65 years of age.",
"     </li>",
"     <li>",
"      A bioprosthetic valve in patients under age 65 who are in sinus rhythm who choose this valve after a detailed discussion of the risks of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy compared to the likelihood of repeat valve replacement in the future.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A mechanical valve is also more appropriate in patients with end-stage renal disease on hemodialysis in whom MS is primarily due to mitral annular calcification. (See",
"    <a class=\"local\" href=\"#H17674209\">",
"     'Mitral annular calcification'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     NONCARDIAC SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of MS has potentially important implications for the perioperative management and prognosis of the patient undergoing noncardiac surgery.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of valvular disease will determine the requirement for antimicrobial prophylaxis for bacterial endocarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H9#H9\">",
"       \"Medical management and indications for intervention in mitral stenosis\", section on 'Prevention of endocarditis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Interruption of chronic anticoagulation may be required prior to surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H10#H10\">",
"       \"Medical management and indications for intervention in mitral stenosis\", section on 'Prevention of thromboembolism'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/50/35626?source=see_link\">",
"       \"Management of anticoagulation before and after elective surgery\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although there are no definitive data, patients with MS who are asymptomatic and do not have pulmonary hypertension or atrial fibrillation probably do not incur an excess risk in noncardiac surgical procedures. In comparison, the prognosis is poor in patients with untreated symptomatic MS. As a result, patients with severe MS should undergo percutaneous or surgical correction of the stenosis prior to noncardiac surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Perioperative considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The perioperative considerations for patients with unoperated MS undergoing noncardiac surgery include attention to the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adequate heart rate control &mdash; Anesthetic agents and muscle relaxants associated with decreased heart rates are preferred, since tachycardia in patients with MS impairs ventricular filling and can result in reduced cardiac output, exacerbation of the transmitral gradient, and possibly pulmonary congestion. Among patients with atrial fibrillation, the ventricular rate should be well controlled prior to elective surgery.",
"     </li>",
"     <li>",
"      Maintenance of systemic vascular resistance &mdash; Mitral stenosis impairs the normal compensatory response associated with a fall in blood pressure, since the stroke volume cannot be substantially increased. As a result, maintenance of systemic vascular resistance is important, since sudden drug-induced reductions in systemic vascular resistance can lead to hypotension.",
"     </li>",
"     <li>",
"      Avoidance of marked increase in central blood volume &mdash; Because of the obstruction to flow from left atrium to left ventricle, any situation that increases venous return and central blood volume will lead to a rise in pulmonary pressures and congestion. As an example, the Trendelenburg position dramatically increases pulmonary blood flow and can cause overt pulmonary edema. Right heart monitoring during surgery is essential to manage the volume status.",
"     </li>",
"     <li>",
"      Avoidance of marked changes in pulmonary vascular resistance &mdash; Some degree of pulmonary hypertension is present in patients with MS. However, an increase in pulmonary hypertension (eg, from arterial hypoxemia) may produce frank right ventricular decompensation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/31/12787?source=see_link\">",
"       \"Patient information: Mitral stenosis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17674230\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mitral stenosis (MS) is a disabling and eventually lethal disease unless treated with valvotomy or valve replacement.",
"     </li>",
"     <li>",
"      When interventions are warranted in patients with rheumatic MS, percutaneous mitral balloon valvotomy (PMBV) is preferred to surgery unless there are contraindications to PMBV. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Rheumatic MS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgery is usually preferred in patients with congenital MS, since the anatomy is complex, the utility of PMBV may be limited, and catheterization procedures are potentially dangerous. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Congenital MS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PMBV and surgical commissurotomy can be repeated as long as the valve morphology remains favorable. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Repeat intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Closed commissurotomy is associated with worse long-term outcomes compared to PMBV and is now rarely performed in developed countries. It is still performed in some developing nations where cost and lack of balloon valvotomy capability are continuing problems. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Closed commissurotomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Open commissurotomy is an appropriate choice in patients with suitable valve morphology who are not candidates for PMBV due to valve deformity or calcification, left atrial thrombus, or significant mitral regurgitation. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Recommendations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with moderate to severe mitral stenosis (mitral valve area &le;1.5 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), NYHA class III or IV symptoms (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 3",
"      </a>",
"      ), and a valve not amenable to either PMBV or open commissurotomy, mitral valve replacement is an option that can significantly improve the natural history of MS.",
"     </li>",
"     <li>",
"      The left atrial appendage is frequently ligated or amputated during mitral valve replacement or open commissurotomy although there are only limited data suggesting that risk of stroke is reduced. (See",
"      <a class=\"local\" href=\"#H40338203\">",
"       'Left atrial appendage ligation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual valve chosen for most patients with MS who require valve replacement is a mechanical prosthesis because the patients are usually relatively young (&lt;70 years old) and most require chronic anticoagulation for atrial fibrillation (the lack of requirement for anticoagulation being a relative advantage of bioprosthetic valves). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Bioprosthesis versus mechanical prosthesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The effective orifice area (EOA) in prosthetic valves used for mitral valve replacement is often small in relation to body size and may be associated with transvalvular pressure gradients similar to those in mild to moderate mitral stenosis. Bioprosthetic valves tend to have higher gradients than mechanical valves but prosthetic valve-patient mismatch can occur with either type of valve. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Prosthetic valve-patient mismatch'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since patients with symptomatic MS tolerate noncardiac surgery, such patients should generally undergo percutaneous or surgical correction of the stenosis prior to noncardiac surgery. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Noncardiac surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/1\">",
"      ROWE JC, BLAND EF, SPRAGUE HB, WHITE PD. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med 1960; 52:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/2\">",
"      Dahl JC, Winchell P, Borden CW. Mitral stenosis. A long term postoperative follow-up. Arch Intern Med 1967; 119:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/3\">",
"      Roy SB, Gopinath N. Mitral stenosis. Circulation 1968; 38:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/4\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/5\">",
"      Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998; 97:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/6\">",
"      Lau KW, Ding ZP, Hung JS. Percutaneous transvenous mitral commissurotomy versus surgical commissurotomy in the treatment of mitral stenosis. Clin Cardiol 1997; 20:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/7\">",
"      Khan MN. The relief of mitral stenosis. An historic step in cardiac surgery. Tex Heart Inst J 1996; 23:258.",
"     </a>",
"    </li>",
"    <li>",
"     Wheeler EO, Wilkins GT, Reynolds TR, et al.. Rheumatic mitral valve disease and tricuspid valve disease. In: The Practice of Cardiology, 2nd ed, Eagle KA, Habe E, DeSanctis R, Austen WG (Eds), Little, Brown, and Company, Boston 1989. p.655.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/9\">",
"      John S, Bashi VV, Jairaj PS, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation 1983; 68:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/10\">",
"      Pavankumar P, Venugopal P, Kaul U, et al. Closed mitral valvotomy during pregnancy. A 20-year experience. Scand J Thorac Cardiovasc Surg 1988; 22:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/11\">",
"      Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994; 331:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/12\">",
"      Cohn LH, Allred EN, Cohn LA, et al. Long-term results of open mitral valve reconstruction for mitral stenosis. Am J Cardiol 1985; 55:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/13\">",
"      Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol 2005; 45:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/14\">",
"      BRAUNWALD E, BRAUNWALD NS, ROSS J Jr, MORROW AG. EFFECTS OF MITRAL-VALVE REPLACEMENT ON THE PULMONARY VASCULAR DYNAMICS OF PATIENTS WITH PULMONARY HYPERTENSION. N Engl J Med 1965; 273:509.",
"     </a>",
"    </li>",
"    <li>",
"     Alpert JS, Sabik J, Cosgrove DM III. Mitral valve disease. In: Textbook of Cardiovascular Medicine, Topol EJ (Ed), Lippincott-Raven, Philadelphia 1998. p.503.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/16\">",
"      Garc&iacute;a-Fern&aacute;ndez MA, P&eacute;rez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003; 42:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/17\">",
"      Appelbaum A, Kouchoukos NT, Blackstone EH, Kirklin JW. Early risks of open heart surgery for mitral valve disease. Am J Cardiol 1976; 37:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/18\">",
"      Feldman T. Rheumatic Mitral Stenosis. Curr Treat Options Cardiovasc Med 2000; 2:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/19\">",
"      Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005; 45:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/20\">",
"      Crawford FA Jr. Residual pulmonary artery hypertension after mitral valve replacement: size matters! J Am Coll Cardiol 2005; 45:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/21\">",
"      Magne J, Mathieu P, Dumesnil JG, et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation 2007; 115:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17480/abstract/22\">",
"      Bolman RM 3rd. Survival after mitral valve replacement: does the valve type and/or size make a difference? Circulation 2007; 115:1336.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8140 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-806F72AFFC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17480=[""].join("\n");
var outline_f17_4_17480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17674230\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CHOICE OF PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Rheumatic MS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Congenital MS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17674209\">",
"      Mitral annular calcification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Repeat intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CORONARY ANGIOGRAPHY PRIOR TO SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLOSED COMMISSUROTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OPEN COMMISSUROTOMY AND VALVE REPAIR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Valvular morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EXERCISE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MITRAL VALVE REPLACEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40338203\">",
"      Left atrial appendage ligation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27859455\">",
"      Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Perioperative mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Risk stratification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bioprosthesis versus mechanical prosthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Prosthetic valve-patient mismatch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      NONCARDIAC SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Perioperative considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17674230\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8140\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8140|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?1/50/1839\" title=\"algorithm 1A\">",
"      Rx MS mild symptoms I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?26/17/26910\" title=\"algorithm 1B\">",
"      Rx MS mild symptoms II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?38/6/39023\" title=\"algorithm 2A\">",
"      Rx MS moderate severe sx I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?34/16/35086\" title=\"algorithm 2B\">",
"      Rx MS moderate severe sx II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?20/38/21103\" title=\"algorithm 3\">",
"      Management asymptomatic MS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8140|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/22/31084\" title=\"table 1\">",
"      Percutaneous mitral valvotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/32/28172\" title=\"table 2\">",
"      ACC AHA surgery mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 3\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/4/29772\" title=\"table 4\">",
"      Coronary angio valve disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25497?source=related_link\">",
"      Complications of prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7252?source=related_link\">",
"      Estimating the mortality risk of valvular surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=related_link\">",
"      Medical management and indications for intervention in mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/58/37801?source=related_link\">",
"      Mitral annular calcification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=related_link\">",
"      Natural history of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21686?source=related_link\">",
"      Nonpharmacologic therapy to prevent embolization in patients with atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=related_link\">",
"      Overview of the management of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/31/12787?source=related_link\">",
"      Patient information: Mitral stenosis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=related_link\">",
"      Percutaneous mitral balloon valvotomy for mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29447?source=related_link\">",
"      Pregnancy in women with mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=related_link\">",
"      Surgical approaches to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=related_link\">",
"      Surgical procedures for severe chronic mitral regurgitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_4_17481="Erythema gyratum repens lesions";
var content_f17_4_17481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57355%7EONC%2F58124%7EDERM%2F68112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57355%7EONC%2F58124%7EDERM%2F68112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema gyratum repens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Concentric erythematous plaques are present on the skin of this patient with erythema gyratum repens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema gyratum repens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 261px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Callen, Jeffrey. Color Atlas of Dermatology. WB Saunders 2000. p.70. Copyright &copy; 2000 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema gyratum repens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple concentric erythematous plaques are present in this patient with erythema gyratum repens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17481=[""].join("\n");
var outline_f17_4_17481=null;
var title_f17_4_17482="Prehospital care of the adult trauma patient";
var content_f17_4_17482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prehospital care of the adult trauma patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Tom Blackwell, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/4/17482/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/4/17482/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concept of emergency medical transport originated from the need to move wounded soldiers from the battlefield to aid stations and other medical facilities [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. In 1865, the first hospital-based ambulance service was developed at the Commercial Hospital in Cincinnati, Ohio. Four years later, New York City's Bellevue Hospital started the first municipal service [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/1\">",
"     1",
"    </a>",
"    ]. During the first half of the 20",
"    <sup>",
"     th",
"    </sup>",
"    century, ambulance services were most often provided by private individuals, particularly morticians as a service to families and to promote their funeral business.",
"   </p>",
"   <p>",
"    Beginning in the mid-1950s in the United States, emergency medical service (EMS) systems began to mature in parallel with the burgeoning interstate highway system. Excessive speeds coupled with poorly designed vehicles had led to an increase in serious vehicular crashes, and few cities possessed the EMS systems needed to manage such patients. Subsequently, a national effort to develop EMS systems was initiated, and standards for provider education, scope of practice, equipment, vehicles, and system design were introduced [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ]. The result was a dramatic improvement in prehospital care.",
"   </p>",
"   <p>",
"    This topic review will discuss prehospital care of the adult trauma patient. Discussions of specific procedures are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EMERGENCY MEDICAL SERVICE (EMS) SYSTEM DESIGN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The priority of any EMS system is to deliver quality patient care in the briefest period of time following injury, regardless of system design or level of care. Wide variation exists in the level and skill of treatment provided in the prehospital setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/6\">",
"     6",
"    </a>",
"    ]. Prehospital medicine typically consists of two levels of care: basic life support (BLS) and advanced life support (ALS).",
"   </p>",
"   <p>",
"    For trauma care, basic skills include airway management (eg, maneuvers to open an airway, oral and nasal airway adjuncts, and bag-mask ventilation), cardiopulmonary resuscitation and automated external defibrillation, hemorrhage control, and fracture and spine immobilization. Emergency medical technicians (EMTs) certified at the basic level (EMT-B) can provide these services.",
"   </p>",
"   <p>",
"    Systems functioning at the ALS level provide more comprehensive management, including advanced airway interventions (eg, endotracheal intubation, cricothyroidotomy), intravenous line placement and fluid administration, medication administration, cardiac monitoring and defibrillation, and needle thoracostomy. Providers certified at the paramedic level (EMT-P) can perform any of these interventions, while providers certified at the intermediate level (EMT-I) can perform a select subset. While EMS systems in most urban and suburban areas function at the ALS level of care, debate continues concerning the effectiveness of ALS interventions for traumatic emergencies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/7-10\">",
"     7-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An EMS medical director is a clinician who has undertaken specialized training and has an understanding of the capacity and extent of prehospital medical management. Directors oversee all aspects of EMS including: communications, clinical management, education, and quality improvement.",
"   </p>",
"   <p>",
"    One important duty of the medical director is to develop patient care protocols, which serve as practice guidelines and standards of care for specific illnesses or injuries. Protocols may include standing orders, which enable prehospital providers to perform specified procedures or to administer medications for predefined conditions without a delay to obtain permission from a clinician.",
"   </p>",
"   <p>",
"    The medical director typically also has the responsibility to develop protocols for triage and hospital notification. Such protocols ensure that receiving hospitals are adequately prepared to mobilize the resources needed to efficiently address any critically ill or injured patients being transported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREHOSPITAL TRAUMA CARE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three critical tasks must be rapidly performed by prehospital providers caring for trauma victims:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For the individual victim: examination with recognition of severe injuries and injuries with potential to cause rapid decompensation",
"     </li>",
"     <li>",
"      For multiple victims: triage with initiation of life-saving treatment",
"     </li>",
"     <li>",
"      Stabilization and transport to a hospital capable of addressing the identified injuries",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rapid transport to the hospital is critically important, and prehospital providers must do all they can to minimize the amount of time spent on scene [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. Conflicting data exist concerning the relative importance of specific procedures in trauma management, but evidence suggests that patient mortality is lower when invasive procedures are performed in the hospital rather than en route [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. Assuming comparable transport times, studies suggest trauma victims do better when cared for by ALS providers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Triage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many forms of triage exist and a full discussion is beyond the scope of this review. Below, we provide an overview of important concepts and scoring systems used for prehospital triage of trauma patients.",
"   </p>",
"   <p>",
"    Triage of trauma victims is the process of rapidly and accurately evaluating patients to determine the extent of their injuries and the appropriate level of medical care required. The goal is to transport all seriously injured patients to medical facilities capable of providing appropriate care, while avoiding unnecessary transport of patients without critical injuries to trauma centers. Overall, triage tools should err on the side of reducing under-triage (ie, increasing sensitivity), at the risk of encouraging over-triage (ie, decreasing specificity). According to the American College of Surgeons, 5 percent is an acceptable under-triage rate, while acceptable over-triage rates may be as high as 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Appropriate prehospital triage of trauma victims depends on a number of variables, including the nature of the incident, the number of victims, available resources, transport time, and the judgment of prehospital caretakers. As an example, triage for a motor vehicle accident with multiple victims involves determining which patients are most severely injured and ensuring that they are immediately transported to a trauma center. Priorities change during a mass casualty incident capable of overwhelming local healthcare resources. In such a circumstance, priority is placed on providing care to victims most likely to survive; victims with such severe injuries that they are unlikely to survive are given low priority because they consume a disproportionate share of resources.",
"   </p>",
"   <p>",
"    Triage scoring systems have been developed to aid prehospital personnel. The ideal prehospital triage tool is simple to use, results in consistent findings when applied by different clinicians, and accurately differentiates between victims with major and minor injuries. No single best scoring system exists: the scoring system selected is based upon the type of incident, personnel, available resources, and the preference of EMS directors. Most scoring systems incorporate several types of criteria to differentiate major from minor trauma, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Physiologic (eg, blood pressure, level of consciousness)",
"     </li>",
"     <li>",
"      Anatomic (eg, long bone fracture, surface area of burn)",
"     </li>",
"     <li>",
"      Mechanistic (eg, height of fall, pedestrian hit by car)",
"     </li>",
"     <li>",
"      Age and comorbidities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Over the past two decades, trauma specialists have developed a number of prehospital triage scoring systems [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/21\">",
"     21",
"    </a>",
"    ]. Most incorporate simple assessments of neurologic, respiratory, and circulatory function. Examples of such triage scoring tools include the Prehospital Index, Revised Trauma Score, CRAMS score (Circulation, Respiration,",
"    <span class=\"nowrap\">",
"     Abdomen/Thorax,",
"    </span>",
"    Motor, Speech), and MGAP (Mechanism, GCS, Age, arterial Pressure) (",
"    <a class=\"graphic graphic_table graphicRef79522 \" href=\"UTD.htm?17/28/17868\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Field personnel created START (Simple Triage and Rapid Treatment) for use as a prehospital triage system utilizing assessment of ambulation, respiration, perfusion, and mental status in a stepwise fashion to determine which victims require immediate transport for definitive care. START is easy to apply and designed for mass casualty incidents when time for comprehensive evaluation is nonexistent.",
"   </p>",
"   <p>",
"    Paramedic judgment is an important component of triage. One observational study found that assessment by experienced urban paramedics is as accurate in identifying critically ill trauma patients as three commonly used scoring systems [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/22\">",
"     22",
"    </a>",
"    ]. Another observational study concluded that prehospital personnel can use a trauma triage tool to identify major trauma victims accurately [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For mass casualty incidents, prehospital triage planning should incorporate an identification system. The Medical Emergency Triage Tags (METTAG&trade;) system is perhaps best known, and is widely used across the United States. The system uses color-coded tags to identify patients and to designate their triage category: black is dead, red is critical, yellow is serious, green is not serious.",
"   </p>",
"   <p>",
"    The United States Centers for Disease Control and Prevention (CDC) has developed guidelines for mass casualty triage to promote consistent management. The CDC's SALT approach (Sort, Assess, Lifesaving interventions, Treatment and transport) was developed on the basis of available evidence and expert consensus, and incorporates variables from several triage systems (",
"    <a class=\"graphic graphic_algorithm graphicRef81002 \" href=\"UTD.htm?22/18/22822\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regardless of the triage system adopted, all prehospital personnel must be familiar with the system and must participate in periodic exercises to retain knowledge and skill.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Initial evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once triage is complete, the sickest viable patients are managed first. The Advanced Trauma Life Support (ATLS) evaluation guidelines put forward by the American College of Surgeons can be usefully applied in the field: primary (focused) assessments are followed by secondary (detailed) assessments. Primary assessment (ie, primary survey) follows the ABCDE pattern: Airway, Breathing, Circulation, Disability (Neurologic status), Exposure.",
"   </p>",
"   <p>",
"    The prehospital provider's first task is to secure the patient's airway. If it is not secure, emergent basic airway management is performed. Interventions may include maneuvers to open and maintain the airway. Manual in-line stabilization of the cervical spine should be performed simultaneously. Airway adjuncts, such as oropharyngeal or nasopharyngeal airways, and suctioning, can be used. If breathing is labored or absent, assisted ventilations should be provided using a bag-valve mask device and high-flow oxygen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the airway and breathing are secure, providers must manage any uncontrolled hemorrhage using direct pressure. Once hemorrhage is controlled, neurologic status is assessed. One simple assessment scheme is AVPU: Alert, responds to Voice, responds to Pain, or Unresponsive. Spinal immobilization is continuously maintained.",
"   </p>",
"   <p>",
"    Next, prehospital personnel place definitive spinal immobilization (ie, rigid cervical collar and backboard). Various techniques may be used to attach the backboard, including the figure-of-eight, where straps are placed diagonally across the chest and lower extremities, or the transverse, where straps are placed straight across the torso and lower extremities. Two points bear emphasis: the immobilization technique must firmly secure the patient to the board such that they (backboard and patient) can be rolled with minimal if any patient movement. Rolling may be needed to prevent aspiration, should the patient vomit. A clinician must perform manual in-line stabilization of the cervical spine while others secure the patient's body to the backboard. Once the body is secured, prehospital personnel may definitively secure the patient's head to the backboard.",
"   </p>",
"   <p>",
"    Patients trapped in a vehicle pose challenging problems for safe extrication. Special care must be taken with patients who have suspected spinal injuries, including those with an altered level of consciousness. For such patients, prehospital personnel can use special devices, such as the Kendrick Extrication Device (KED&reg;). These short backboards effectively immobilize the mid-back and cervical region prior to moving the trapped patient. Although use of these devices may prolong scene time, the benefit may outweigh the risk for patients with potentially unstable spinal injuries.",
"   </p>",
"   <p>",
"    Prehospital providers obtain vital signs as part of their assessment of patient circulation. Ideally, blood pressure measurements are obtained in each arm. Several observational studies suggest that prehospital hypotension is associated with an increased need for emergent surgery and with increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. The presence of prehospital hypotension must be clearly communicated to the emergency department clinicians assuming care of the patient.",
"   </p>",
"   <p>",
"    The final primary assessment is an evaluation of the entire patient. Prehospital providers must be compulsive about removing enough clothing to assess critical areas of the body for obvious and occult injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Secondary survey",
"    </span>",
"    &nbsp;&mdash;&nbsp;After completion of the initial assessment and stabilizing treatments, the prehospital provider performs a quick but thorough review of the entire body, referred to as the secondary survey. The goal is to discern and manage as appropriate any injuries missed during the primary survey.",
"   </p>",
"   <p>",
"    Common pitfalls include not thoroughly inspecting the back, the axillae, the gluteal region, and pannicular folds. Such inspection is particularly important if the clinician suspects penetrating trauma. Providers must also assess for pelvic instability and, if present, attempt to provide stability and control retroperitoneal hemorrhage by applying a pelvic binder. A binder can be a prefabricated device or something as simple as a sheet wrapped tightly around the patient's pelvis and tied in place. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=see_link\">",
"     \"Pelvic trauma: Initial evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following the secondary survey, the patient should be prepared for transport. Performing full spinal immobilization is prudent; prolonging scene time to initiate intravenous lines, bandage non-hemorrhaging wounds, or splint minor fractures is unnecessary and potentially deleterious.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Airway support",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Controversies and guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway management techniques are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=see_link\">",
"     \"Direct laryngoscopy and tracheal intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While basic measures to protect the airway are valuable, definitive airway control with endotracheal intubation (ETI) is often needed for severely injured patients. Whether ETI should be performed in the prehospital setting is controversial. A systematic review found a dearth of rigorous studies addressing ETI in acutely ill and injured patients and concluded that there is \"no imperative\" to the performance of prehospital intubation in urban trauma patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some researchers claim prehospital ETI improves outcomes. In one retrospective case-control study performed in a large urban emergency medical services (EMS) system, researchers found that field intubation was associated with a decrease in mortality among 671 patients with severe head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/30\">",
"     30",
"    </a>",
"    ]. In this study researchers stratified patients by their Glasgow Coma Scale (GCS), but did not adjust for their Injury Severity Score, or comparable measures. A small number of studies have found a similar association between field ETI and improved survival [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, many researchers have found increased morbidity and mortality among patients intubated in the field and question the benefit of this practice [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/16,32-42\">",
"     16,32-42",
"    </a>",
"    ]. They attribute worse outcomes to delays in transport, improperly placed endotracheal tubes, improper ventilation, aspiration, and other complications. One retrospective review of 496 patients who received airway support from paramedics working in a major urban EMS system found that patients assisted with bag mask ventilation (BMV) were more likely to survive than those treated with ETI [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/33\">",
"     33",
"    </a>",
"    ]. After controlling for injury severity, these researchers found the survival rate of patients receiving ventilation by BMV to be 5.3 times higher than patients managed with ETI (95 percent CI 2.3-14.2). Others have found similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether drug-assisted intubation (DAI) or rapid sequence intubation (RSI) should be performed in the prehospital environment also remains controversial. RSI is commonly performed by air medical programs and is used successfully by some ground EMS systems [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/30,43-47\">",
"     30,43-47",
"    </a>",
"    ]. Nevertheless, several studies have noted many of the same complications observed with standard ETI in patients receiving RSI [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/36,48-50\">",
"     36,48-50",
"    </a>",
"    ]. As an example, one prospective study of prehospital RSI in patients with severe head injury, performed in a major urban EMS system, compared 209 patients treated with RSI to 627 matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/48\">",
"     48",
"    </a>",
"    ]. The authors found a significant increase in mortality and morbidity among patients managed with RSI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Controversy about whether to perform prehospital RSI, particularly where transport times are brief, will likely persist until large prospective randomized controlled trials are conducted to determine how the technique affects patient outcomes. Until then, EMS programs incorporating RSI into their management protocols should strive to ensure their paramedics perform the procedure properly. Effective training and regular retraining, close monitoring, and regular performance of the procedure by a core group of paramedics can help accomplish this [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Airway training for EMS providers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    EMS systems that permit prehospital ETI, especially those incorporating RSI, must include protocols with procedures for confirmation of proper tube placement in the airway. Paramedics often confirm placement by auscultating bilateral breath sounds and noting absent gastric sounds, but this approach is often inaccurate and difficult to perform in the austere prehospital environment [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/52\">",
"     52",
"    </a>",
"    ]. End-tidal CO2 (either qualitative by color change or quantitative measurement using numerical values or waveforms from in-line or side-stream devices) provides a more accurate assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Pulse oximetry is also important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prehospital ETI protocols must include a rescue device for failed airway management. Examples include the Combitube&trade; and the Laryngeal Mask Airway (LMA&trade;). Paramedics must maintain skill in employing the selected rescue device and should not hesitate to implement it should they encounter a difficult airway or fail at three attempts to place an endotracheal tube. The dangers of delayed transport and prolonged hypoxia argue against prolonged prehospital attempts at ETI.",
"   </p>",
"   <p>",
"    Providing appropriate respiratory rates and tidal volumes is crucial for all trauma patients. Hyperventilation can result in hyperinflated lungs, which decreases preload and compromises cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/16\">",
"     16",
"    </a>",
"    ]. Hyperventilation can also cause or exacerbate elevated airway pressures, predisposing to pneumothorax. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link&amp;anchor=H17#H17\">",
"     \"Basic airway management in adults\", section on 'Ventilation volumes, rates, and cadence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Head injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with blunt head injury pose special problems, and debate continues concerning whether these patients should be intubated outside the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/30,34-36,48\">",
"     30,34-36,48",
"    </a>",
"    ]. Most important in the prehospital setting is to protect the airway and control the ventilation of head-injured patients in the least invasive manner, thereby minimizing elevations in intracranial pressure. If transport time is brief, often bag-mask ventilation (BMV) alone is sufficient. Successful BMV is critical: it provides immediate oxygenation and ensures that ventilation can be maintained should attempts at more invasive airway management fail. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Should prehospital providers encounter a head-injured patient with a clenched jaw or other airway-compromising conditions, the first step is to perform manual maneuvers (eg, jaw thrust) to open the airway and then provide adequate BMV. Nasal or oropharyngeal airways can help maintain airway patency. Care must be taken to maintain cervical immobilization.",
"   </p>",
"   <p>",
"    In EMS systems with protocols for prehospital intubation, paramedics may determine that endotracheal intubation is needed. Intubation should be performed with speed and finesse in the head-injured patient in order to minimize airway manipulation, which can elevate intracranial pressure and exacerbate the underlying head injury.",
"   </p>",
"   <p>",
"    In addition to airway protection, head-injured patients are intubated in order to control their ventilation rates and maintain their end-tidal CO2 levels between 33 and 35 mmHg. Doing so prevents elevations in intracranial pressure (ICP), thereby helping to maintain adequate cerebral perfusion pressure. Previously, hyperventilation was thought necessary to lower ICP, but this is not so. Ventilation rates typically less than 15 breaths per minute are sufficient [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Moving intubated patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intubated patient should be moved carefully with special attention paid to preventing displacement of the endotracheal tube (ETT) and intravenous lines. The provider in charge of the airway orchestrates all patient movement. Many endotracheal tubes have been removed or displaced into the esophagus from failure to coordinate patient transport appropriately [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/56\">",
"     56",
"    </a>",
"    ]. Proper technique for transferring the intubated patient includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Limited hyperventilation prior to moving",
"     </li>",
"     <li>",
"      Removing the bag-valve mask device prior to moving",
"     </li>",
"     <li>",
"      Holding the tube securely at the lips throughout the move",
"     </li>",
"     <li>",
"      Using clear, verbal commands to coordinate the move",
"     </li>",
"     <li>",
"      Immediately reattaching the bag-valve mask after the move",
"     </li>",
"     <li>",
"      Reassessing ETT placement once the move is complete (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"       \"Carbon dioxide monitoring (capnography)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Airway training for EMS providers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful prehospital advanced airway management depends upon proper training and oversight. EMS directors must design and implement educational and quality management programs for advanced airway management that are comprehensive and stringent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/51,57\">",
"     51,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To be successful in advanced airway management, prehospital advanced life support (ALS) providers need cognitive and technical skills, and must understand the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Airway assessment",
"     </li>",
"     <li>",
"      Indications for endotracheal intubation (ETI)",
"     </li>",
"     <li>",
"      Common clinical scenarios in which ETI is needed",
"     </li>",
"     <li>",
"      Major complications of ETI",
"     </li>",
"     <li>",
"      A range of airway management techniques, including bag-mask ventilation, ETI, and rescue airways",
"     </li>",
"     <li>",
"      Confirmation of proper endotracheal tube placement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The number of supervised endotracheal intubations (ETI) a paramedic should perform before operating independently is unknown. Furthermore, no universal training standards exist for paramedics, despite their being charged with managing the airway under the most difficult conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/45,55,56,58\">",
"     45,55,56,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prehospital providers should learn basic technical skills in airway management during classroom training sessions taught by experienced airway managers. Additional skill can be gained by performing techniques on patients in the operating room under the supervision of anesthesiologists. Such opportunities may be limited, however, and alternative experiences such as high-fidelity simulation (HFS), can be extremely useful in developing cognitive and technical airway management skills [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Regular retraining using HFS can help prehospital providers maintain competency.",
"   </p>",
"   <p>",
"    Experience in airway management is best provided to paramedic trainees in the emergency department, which more closely approximates the clinical conditions found outside the hospital (eg, combative patients, blood and vomit in the airway). In addition to basic airway procedures and endotracheal intubation, ALS providers must be facile with airway adjuncts (eg, Laryngeal mask airway, LMA&trade;) and able to confirm proper placement of the endotracheal tube using end-tidal CO2 detectors and other techniques. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hemorrhage control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basic measures for controlling hemorrhage consist of direct pressure to the wound followed by pressure dressings, with elevation and pressure points used as adjuncts. When penetrating trauma occurs to certain anatomic areas, hemorrhage control may be difficult with pressure dressings alone. As an example, gross hemorrhage may not be apparent with gunshot wounds to the thigh. In such circumstances, direct manual pressure must be applied throughout the prehospital phase of care to ensure that occult, internal bleeding is controlled as well as possible. In uncommon instances (eg, injury from an explosion), application of a tourniquet may be necessary to control life-threatening bleeding from a severe extremity wound [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/61-64\">",
"     61-64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of topical hemorrhage control agents are being developed, but they require further study before widespread use in civilian populations can be recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=see_link\">",
"     \"Initial evaluation and management of shock in adult trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unstable pelvic injuries, such as \"open-book\" fractures involving disruption of the sacroiliac joints, are associated with retroperitoneal hemorrhage. Prehospital treatment for this injury consists of \"closing\" the fracture by securing a pelvic binder or sheet tightly around the pelvis. Serial exams of pelvic fractures should",
"    <strong>",
"     NOT",
"    </strong>",
"    be performed in order to avoid exacerbating retroperitoneal hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=see_link\">",
"     \"Pelvic trauma: Initial evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Intravenous (IV) fluids",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the need for fluid resuscitation or IV medications is apparent or anticipated, EMS personnel place two large-bore (16 gauge or larger) IV lines. If possible, placement should be performed during transport to avoid prolonging scene times [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"     66",
"    </a>",
"    ]. When peripheral IV access is difficult or impossible, an intraosseous (IO) line may be used for adults or children. Preliminary observational data suggest that several devices are effective at establishing IO access in the prehospital setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/67-69\">",
"     67-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    According to a systematic review of studies of prehospital fluid resuscitation, weak evidence suggests that trauma patients with signs of hypovolemic shock are best treated with a discrete bolus of IV fluid (eg, 250 mL of isotonic saline) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"     66",
"    </a>",
"    ]. EMS personnel can give repeat boluses to maintain an adequate pulse and blood pressure. Pressure bags or rapid infusion pumps should not be used [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of hemodynamic instability from traumatic injury with high-volume IV fluid resuscitation has been standard in most EMS systems. However, the use of copious IV fluid replacement to achieve normal or near-normal blood pressures for uncontrolled hemorrhagic shock is controversial and evidence supporting this approach is scant [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some researchers question the need for prehospital high-volume resuscitation and advocate restricted use of IV fluids. They theorize that increasing mean arterial pressure to near-normal levels with aggressive IV fluid replacement, prior to achieving surgical hemostasis, may result in hemodilution, decreased oxygen-carrying capacity, dilution of clotting factors, and disruption of tenuous clots at sites of injury. An alternative approach, termed limited volume or \"hypotensive\" resuscitation in trauma, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=see_link&amp;anchor=H9#H9\">",
"     \"Initial evaluation and management of shock in adult trauma\", section on 'Delayed fluid resuscitation/controlled hypotension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While the importance of maintaining end-organ and cerebral perfusion remains unquestionable, the ideal mean arterial pressure to achieve this goal without causing potential harm is unknown. Maintaining such an ideal blood pressure, even if it were known, would be extremely difficult in the prehospital setting. Pending further research, we believe it is reasonable to withhold IV fluid during brief prehospital transport in patients with isolated penetrating torso injuries whose systolic blood pressure is &ge;90 mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The type of IV fluid most suitable for the initial resuscitation of trauma patients in hemorrhagic shock is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=see_link&amp;anchor=H8#H8\">",
"     \"Initial evaluation and management of shock in adult trauma\", section on 'Intravenous fluid resuscitation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Spinal immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most EMS systems, paramedics do not perform prehospital clearance of cervical spine injury. Some EMS systems use clinical criteria, such as those from the National Emergency X-Ray Utilization Study (NEXUS) or Canadian C-spine rule, to rule out cervical spine injury in the prehospital setting. These criteria and spinal immobilization of pediatric patients are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=see_link\">",
"     \"Evaluation and acute management of cervical spinal column injuries in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Observational studies of interrater reliability between emergency clinicians and prehospital providers in the application of clinical guidelines to rule out cervical spine injury have shown mixed results [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/70-72\">",
"     70-72",
"    </a>",
"    ]. Should EMS directors decide to incorporate prehospital clearance of cervical injury, they must ensure their prehospital providers are knowledgeable and skilled in the application of clinical criteria to avoid missing spinal injuries.",
"   </p>",
"   <p>",
"    Proper spinal immobilization includes placement of a hard cervical collar, barriers to lateral head movement (eg, foam pads, rolled towels), and a long backboard. When rolling patients to place them on the long board, providers should inspect the back and palpate the spinal column for step-off and tenderness. Alternative transfer techniques, such as the lift-and-slide, may reduce spine motion in patients with suspected thoracolumbar injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/73\">",
"     73",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Initial evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;If time allows, long-bone fractures can be stabilized or splinted during transport. By splinting and applying traction to obvious femur fractures, providers may reduce pain and minimize soft tissue damage and bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27340367\">",
"    <span class=\"h2\">",
"     Pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prehospital providers often fail to provide adequate analgesia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. Providing analgesics en route to the hospital is important not only for immediate pain relief, but also because it may improve pain treatment in the emergency department [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/77\">",
"     77",
"    </a>",
"    ]. Reluctance to provide analgesia in the prehospital setting may stem from a lack of adequate, age-appropriate assessment protocols, or from concern about the patient's condition. Concerns may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Contributing to diagnostic uncertainty by masking symptoms",
"     </li>",
"     <li>",
"      Exacerbating hemodynamic instability",
"     </li>",
"     <li>",
"      Blunting respiratory drive in a patient with breathing difficulty",
"     </li>",
"     <li>",
"      Exacerbating the condition of a patient with an altered level of consciousness following an injury",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these concerns, judicious use of short-acting opioids for patients in obvious pain is generally safe and effective, and will not mask significant injuries or alter outcome. There is no reason to withhold pain medications for conditions such as isolated extremity injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is a short-acting opioid with rapid onset of effect and is less likely to cause hypotension than other opioids and so is the preferred agent in the trauma patient at risk for hemodynamic instability; doses up to 100 or 150 micrograms IV or IM can be used in patients without hypotension. The results of several observational studies suggest that fentanyl can be given safely to trauma patients in the prehospital setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/79-81\">",
"     79-81",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    may be used but it has a longer duration of effect and is more likely to cause hypotension; doses up to 10 or 15 mg IV or IM can be used in patients without hypotension.",
"   </p>",
"   <p>",
"    For patients in severe pain but with hemodynamic instability, paramedics can give 25 mcg doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    (or 2 mg doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    ) approximately every 10 minutes, while being prepared to give an IV fluid bolus for hypotension. Judicious use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    may be needed for refractory hypotension. Prehospital providers should carefully monitor the respiratory and hemodynamic status of all patients receiving opioids.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     Ketamine",
"    </a>",
"    is being studied as an analgesic for trauma patients in the prehospital setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/82\">",
"     82",
"    </a>",
"    ]. However, we believe the potential risks associated with ketamine, including general disorientation and elevated intracranial pressure in patients with head injuries, are too great and, pending further research, we do not suggest it be used in the prehospital treatment of trauma-related pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once prepared for transport, providers must determine which hospital is most appropriate for the patient. Most metropolitan area ambulance services have access to level one, level two, and level three trauma centers. The American College of Surgeons has established these hospital designations based on specific criteria (eg, availability of neurosurgery or pediatric surgery) to improve the care of trauma victims. Level one and level two centers are comparable in their clinical capacities; level one centers are generally academic institutions with additional research and educational obligations.",
"   </p>",
"   <p>",
"    Little research has been done to determine which patients are best served by direct transport to a level one trauma center, and guidelines are often determined locally. Among the general indications are the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemodynamic instability in a patient with blunt or penetrating injuries to the torso or head",
"     </li>",
"     <li>",
"      Significant burns (eg, greater than 25 percent body surface area, inhalation injury, high voltage electrical source)",
"     </li>",
"     <li>",
"      Spinal injury with a neurologic deficit",
"     </li>",
"     <li>",
"      Significant upper or lower extremity amputation",
"     </li>",
"     <li>",
"      Injury severity score &ge;15",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Providers should notify the receiving facility as early as possible to ensure that hospital staff have adequate time to warn needed personnel (eg, surgeons, interventional radiologists) and prepare equipment (eg, airway devices, operating rooms, CT scanners). This is especially important for systems using trauma teams.",
"   </p>",
"   <p>",
"    During hospital transport, providers should continuously reassess the patient's vital signs and clinical status until arrival at the hospital. Three-lead cardiac and pulse oximetry monitoring should be continuously performed en route. End-tidal CO2 readings of intubated patients should be continuously monitored to help maintain proper ventilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SPECIALIZED PROCEDURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Needle and surgical cricothyroidotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Needle cricothyroidotomy, which permits percutaneous transtracheal ventilation, may be necessary as a last resort to provide oxygenation and ventilation when conventional means of airway support have failed or cannot be performed. As an example, in the presence of massive facial trauma, providers may not be able to discern anatomic landmarks or maintain an adequate mask seal. Copious amounts of blood or secretions can interfere with airway procedures, and may necessitate cricothyroidotomy.",
"   </p>",
"   <p>",
"    For needle cricothyroidotomy, a standard 14-gauge angiocath is acceptable for most adults. The skin over the insertion site should be cleaned with providine-iodine. Once the catheter is properly inserted and the needle removed, ventilation is performed. Should a prefabricated jet ventilation system be unavailable, emergency medical service (EMS) providers may use a bag-valve mask device connected to a 3.0 or 3.5 mm pediatric endotracheal tube adapter. This alternative is a less satisfactory means of ventilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/3/16441?source=see_link\">",
"     \"Needle cricothyroidotomy with percutaneous transtracheal ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cricothyroidotomy enables the clinician to maintain oxygenation, but hypercapnea develops after approximately 20 minutes. Complications of needle cricothyroidotomy include improper catheter placement, bleeding, barotrauma, and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical cricothyroidotomy poses greater risks and potential complications because it is more invasive. With greater availability of effective airway adjuncts (eg, Laryngeal Mask Airway&trade;, Pharyngeal Tracheal Lumen (PTL&reg;) airway, and Combitube&trade;), EMS providers may have less need to resort to needle and surgical cricothyrotomy. Maintaining adequate skill can be problematic for many prehospital providers, and as skills decline, so do patient outcomes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=see_link\">",
"     \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Needle chest decompression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Needle thoracostomy may be life-saving for patients in shock from a tension pneumothorax. However, the procedure increases morbidity if performed when tension pneumothorax is suspected but absent.",
"   </p>",
"   <p>",
"    In the field, prehospital providers may have difficulty confirming the presence of a tension pneumothorax. The mechanism of injury may be suggestive, but physical findings such as diminished breath sounds, distended neck veins, and tracheal deviation, can be unreliable [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. A patient with a tension pneumothorax may tolerate the condition until arrival at the hospital, where clinical examination or a chest radiograph will discern its presence. If there is high clinical suspicion of a tension pneumothorax (eg, unrestrained driver with rib fractures and dyspnea) and the patient develops significant hypotension, the EMS provider should perform emergent needle thoracostomy.",
"   </p>",
"   <p>",
"    Several studies have evaluated the utility of prehospital needle decompression for suspected tension pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. In a large, prospective, observational study, researchers at a major urban trauma center assessed the frequency and utility of needle thoracostomy in over 6000 trauma patients and found that the procedure, while seldom performed, may improve outcome in a small number of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other studies have questioned the utility of the procedure in the prehospital setting. Of over 2000 trauma patients in another observational study, 19 received prehospital needle decompression after trauma, but only four showed evidence of tension physiology, defined by the presence of a pneumothorax with an air leak after tube thoracostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/87\">",
"     87",
"    </a>",
"    ]. The authors concluded that needle thoracostomy is often ineffective and may be overused. A study of 33 medical and trauma patients who received needle decompression found that 14 patients who presented in cardiac arrest had no change in outcome, and only 10 patients had clinical evidence of a pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/86\">",
"     86",
"    </a>",
"    ]. None of the four patients who survived had hemodynamic or respiratory instability prior to decompression.",
"   </p>",
"   <p>",
"    Based on these studies, we recognize it can be difficult to determine when prehospital needle thoracostomy should be performed, but suggest the procedure is most likely to be useful under the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mechanism of injury suggests the likelihood of pneumothorax",
"     </li>",
"     <li>",
"      Patient is in respiratory distress, based on clinical signs and symptoms, and low pulse oximetry despite supplemental oxygen",
"     </li>",
"     <li>",
"      Hemodynamic instability is present",
"     </li>",
"     <li>",
"      Transport time is prolonged",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Providers should be aware that a tension pneumothorax can be localized, and that needle thoracostomy may not be effective in such circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acceptable sites for insertion of a 14-gauge angiocath include the second or third intercostal space in the midclavicular line, or the fifth intercostal space in the midaxillary line. Needles as long as 7 cm may be required to perform the technique effectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/90-94\">",
"     90-94",
"    </a>",
"    ]. We suggest using the anterior site for prehospital treatment. Direct stabilization and continued observation can be performed more easily in a moving ambulance using the anterior site; catheters placed at the lateral site may be dislodged by the patient's arm. The skin should be cleaned with providine-iodine prior to insertion of the needle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SPECIAL ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Air medical services",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of air transport of patients dates to World War I, but its role was expanded dramatically during the Korean and Vietnam conflicts. The first hospital-based air medical service began in Denver at St. Anthony hospital in 1972. Helicopters are used to transport patients between hospitals and from trauma scenes; fixed-wing aircraft are used for long-distance transports.",
"   </p>",
"   <p>",
"    The advantages of medical transport by helicopter may include providing a higher level of care at the scene of trauma and improving access to trauma centers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/95\">",
"     95",
"    </a>",
"    ]. Helicopter-based emergency medical service (EMS) also provides critical care capabilities during interfacility transport from community hospitals to trauma centers.",
"   </p>",
"   <p>",
"    Effective use of helicopter services for trauma depends on the ground responder's ability to determine whether the patient's condition warrants air medical transport. Protocols and training must be developed to ensure appropriate triage criteria are applied. Excessively stringent criteria can prevent rapid care and transport of trauma victims; lax criteria can result in the embarrassing and costly situation of transporting a patient by helicopter only to have the patient discharged in good condition from the emergency department.",
"   </p>",
"   <p>",
"    Crew and patient safety is the single most important factor to be considered when deciding whether to transport a patient by helicopter. Weather, air traffic patterns, and distances (eg, from trauma scene to closest level one trauma center) must also be considered.",
"   </p>",
"   <p>",
"    Some have questioned the safety of air medical services [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. While the number of crashes may be increasing, the number of programs and use of services has also increased [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/98\">",
"     98",
"    </a>",
"    ]. Factors associated with fatal crashes of medical transport helicopters include flying at night and during bad weather, and post-crash fires [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Burn management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prehospital treatment of burn patients begins with stabilization of the airway, breathing, and circulation. Patients with signs of active or impending airway compromise should be treated with immediate endotracheal intubation. Allowing airway swelling from inhalational injury to progress without intervention can create extraordinarily difficult airway management situations, leading to increased morbidity and possibly death. Treatment of major burns is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Common signs of significant smoke inhalation injury and the potential need for intubation include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Persistent cough, stridor or wheezing",
"     </li>",
"     <li>",
"      Hoarseness",
"     </li>",
"     <li>",
"      Deep facial or circumferential neck burns",
"     </li>",
"     <li>",
"      Nares with inflammation or singed hair",
"     </li>",
"     <li>",
"      Carbonaceous sputum or burnt matter in mouth or nose",
"     </li>",
"     <li>",
"      Blistering or edema of the oropharynx",
"     </li>",
"     <li>",
"      Depressed mental status, including evidence of drug or alcohol use",
"     </li>",
"     <li>",
"      Respiratory distress",
"     </li>",
"     <li>",
"      Hypoxia or hypercapnia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Providers should determine the severity (eg, full-thickness versus partial-thickness) and extent (ie, percent body surface area) of the burn. These calculations are used to determine the amount of intravenous (IV) fluid resuscitation required. Aggressive fluid resuscitation should begin immediately for any patient with burn shock or major burns.",
"   </p>",
"   <p>",
"    According to the Parkland (or Baxter) formula, the fluid requirement during the initial 24 hours of treatment is 4",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of body weight for each percent of TBSA burned, given IV. Superficial burns are excluded from this calculation. One-half of the calculated fluid need is given in the first eight hours. IV fluid boluses to maintain blood pressure are given in addition to the calculated fluid requirements based on burn size.",
"   </p>",
"   <p>",
"    Other treatments to consider, if time is available, include wound cooling and dressing. While rapid cooling is desirable and must be performed within 30 minutes to be effective, it may result in hypothermia if performed over an extensive surface area. Isolated extremity burns may be cooled immediately; more extensive burns should be covered with dry, clean sheets or other appropriate dressings. The ambulance should be heated to help prevent hypothermia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37479?source=see_link\">",
"     \"Treatment of minor thermal burns\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with significant burns should be transported directly to facilities capable of providing comprehensive burn care. If no such facility exists locally, the patient is brought to the closest hospital able to provide initial stabilization and arrange secondary transport to a designated referral burn center. According to the American Burn Association, significant burns include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Burns covering over 20 percent of total body surface area in adults, or over 10 percent in young children or the elderly",
"     </li>",
"     <li>",
"      Full-thickness burns covering over 5 percent of total body surface area",
"     </li>",
"     <li>",
"      Burns involving the face, eyes, ears, hands, feet, or perineum",
"     </li>",
"     <li>",
"      Burns crossing major joints or circumferential extremity burns",
"     </li>",
"     <li>",
"      High voltage electrical burns",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with burns from suspected abuse or burns associated with major trauma, and patients with comorbidities increasing the risk of infection (eg, diabetes mellitus), should be hospitalized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Prehospital determination of death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prehospital providers may withhold life support in certain situations. As an example, providers need not provide care to patients with injuries that are incompatible with life (eg, burned beyond recognition, decapitated, blunt trauma to the abdomen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chest without vital signs), or those with obvious signs of death (eg, postmortem lividity, rigor mortis, or gross decomposition). Caution should be exercised when developing protocols paramedics can use to withhold care. Some states may have regulations that limit the prehospital provider's ability to make such determinations.",
"   </p>",
"   <p>",
"    After resuscitation has been initiated, there may be circumstances when it is reasonable for prehospital providers to cease their efforts and pronounce the patient dead. Clinical circumstances (eg, blunt versus penetrating trauma) play a role in such decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?17/4/17482/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In all cases where prehospital providers pronounce death after stopping resuscitative efforts, they should perform and record the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete set of vital signs",
"     </li>",
"     <li>",
"      Cardiac monitor rhythm strip from multiple leads, including printed copies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three critical tasks must be rapidly performed by prehospital providers caring for trauma victims (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For the individual victim: examination with recognition of severe injuries and injuries with potential to cause rapid decompensation",
"     </li>",
"     <li>",
"      For multiple victims: triage with initiation of life-saving treatment (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Triage'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Stabilization and transport to a hospital capable of addressing the identified injuries. Prehospital providers must do all they can to minimize the amount of time spent on scene. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Transport'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assessment and stabilization of the trauma victim follow the ABCDE pattern: Airway, Breathing, Circulation, Disability (Neurologic status), Exposure. The prehospital provider's first task is to secure the patient's airway. If it is not secure, emergent basic airway management is performed. Once the airway and breathing are secure, providers manage any uncontrolled hemorrhage using direct pressure. The cervical spine is immobilized to prevent injury. Proper spinal immobilization includes placement of a hard cervical collar, barriers to lateral head movement (eg, foam pads, rolled towels), and a long backboard. Vital signs are obtained. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Spinal immobilization'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"       \"Basic airway management in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After completion of the initial assessment and stabilizing treatments, the prehospital provider performs a quick but thorough review of the entire body to discern and manage any injuries missed during the primary survey. Common pitfalls include not thoroughly inspecting the back, the axillae, the gluteal region, and pannicular folds. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Secondary survey'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prehospital endotracheal intubation (ETI) is controversial. EMS systems that permit prehospital ETI, especially those incorporating rapid sequence intubation (RSI), must include protocols and equipment (eg, End-tidal CO2 monitor) for confirmation of proper tracheal tube placement, and a rescue device for failed airway management. Paramedics must maintain skill in employing the selected rescue device and should use it if they encounter a difficult airway or fail at three attempts to place a tracheal tube. The dangers of delayed transport and prolonged hypoxia argue against prolonged prehospital attempts at ETI. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Airway support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Providing appropriate respiratory rates and tidal volumes is crucial for all trauma patients. Hyperventilation can result in hyperinflated lungs, which decreases preload and compromises cardiac output. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Airway support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Basic measures for controlling hemorrhage consist of direct pressure followed by pressure dressings, with elevation and pressure points used as adjuncts. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Hemorrhage control'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Intravenous (IV) fluids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unstable pelvic injuries, such as \"open-book\" fractures involving disruption of the sacroiliac joints, are associated with retroperitoneal hemorrhage. Prehospital treatment for this injury consists of \"closing\" the fracture by securing a pelvic binder or sheet tightly around the pelvis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Hemorrhage control'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Intravenous (IV) fluids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Burn patients with signs of airway compromise or impending compromise should be treated with immediate tracheal intubation, if the prehospital provider is skilled in the procedure. Signs of airway compromise are described in the text. Severe burn victims require aggressive fluid resuscitation. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Burn management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prehospital providers often fail to provide adequate analgesia. Judicious use of short-acting opioids (eg, IV",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      up to 100 or 150 mcg, or IV",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      up to 10 or 15 mg) for patients in obvious pain is generally safe and effective, and will not mask significant injuries or alter outcome. Paramedics may treat patients with severe pain and hemodynamic instability with 25 mcg doses of IV fentanyl (or 2 mg doses of IV morphine) approximately every 10 minutes, while being prepared to give an IV fluid bolus. Paramedics should carefully monitor the respiratory and hemodynamic status of any patient receiving opioids. (See",
"      <a class=\"local\" href=\"#H27340367\">",
"       'Pain management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2194152\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Barkley KT. Ambulances of the future. In: The Ambulance: The Story of Emergency Transportation of the sick and wounded through the centuries, Kiamesha Lake, New York 1978. p.171.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/2\">",
"      Brewer LA 3rd. Baron Dominique Jean Larrey (1766-1842). Father of modern military surgery, innovater, humanist. J Thorac Cardiovasc Surg 1986; 92:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/3\">",
"      Boyd DR. The conceptual development of EMS systems in the United States, Part I. Emerg Med Serv 1982; 11:19.",
"     </a>",
"    </li>",
"    <li>",
"     Law of the 89th Congress: National Highway Safety Act of 1966, Public Law 89-564, Washington, DC, 1966.",
"    </li>",
"    <li>",
"     Law of the 93rd Congress: Emergency Medical Services Systems Act of 1973, Public Law 93-154, Washington, DC, 1973.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/6\">",
"      Bulger EM, Nathens AB, Rivara FP, et al. National variability in out-of-hospital treatment after traumatic injury. Ann Emerg Med 2007; 49:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/7\">",
"      Osterwalder JJ. Mortality of blunt polytrauma: a comparison between emergency physicians and emergency medical technicians--prospective cohort study at a level I hospital in eastern Switzerland. J Trauma 2003; 55:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/8\">",
"      Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/9\">",
"      Stiell IG, Nesbitt LP, Pickett W, et al. The OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity. CMAJ 2008; 178:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/10\">",
"      Liberman M, Mulder D, Lavoie A, et al. Multicenter Canadian study of prehospital trauma care. Ann Surg 2003; 237:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/11\">",
"      Smith JP, Bodai BI. The urban paramedic's scope of practice. JAMA 1985; 253:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/12\">",
"      Feero S, Hedges JR, Simmons E, Irwin L. Does out-of-hospital EMS time affect trauma survival? Am J Emerg Med 1995; 13:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/13\">",
"      Gonzalez RP, Cummings GR, Phelan HA, et al. Does increased emergency medical services prehospital time affect patient mortality in rural motor vehicle crashes? A statewide analysis. Am J Surg 2009; 197:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/14\">",
"      McCoy CE, Menchine M, Sampson S, et al. Emergency medical services out-of-hospital scene and transport times and their association with mortality in trauma patients presenting to an urban Level I trauma center. Ann Emerg Med 2013; 61:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/15\">",
"      Gervin AS, Fischer RP. The importance of prompt transport of salvage of patients with penetrating heart wounds. J Trauma 1982; 22:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/16\">",
"      Shafi S, Gentilello L. Pre-hospital endotracheal intubation and positive pressure ventilation is associated with hypotension and decreased survival in hypovolemic trauma patients: an analysis of the National Trauma Data Bank. J Trauma 2005; 59:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/17\">",
"      Smith JP, Bodai BI, Hill AS, Frey CF. Prehospital stabilization of critically injured patients: a failed concept. J Trauma 1985; 25:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/18\">",
"      Liberman M, Mulder D, Sampalis J. Advanced or basic life support for trauma: meta-analysis and critical review of the literature. J Trauma 2000; 49:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/19\">",
"      Jacobs LM, Sinclair A, Beiser A, D'Agostino RB. Prehospital advanced life support: benefits in trauma. J Trauma 1984; 24:8.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Surgeons Committee on Trauma. Prehospital trauma care. In: Resources for Optimal Care of the Injured Patient. American College of Surgeons, Chicago, IL 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/21\">",
"      Lerner EB. Studies evaluating current field triage: 1966-2005. Prehosp Emerg Care 2006; 10:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/22\">",
"      Emerman CL, Shade B, Kubincanek J. A comparison of EMT judgment and prehospital trauma triage instruments. J Trauma 1991; 31:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/23\">",
"      Purtill MA, Benedict K, Hernandez-Boussard T, et al. Validation of a prehospital trauma triage tool: a 10-year perspective. J Trauma 2008; 65:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/24\">",
"      Sasser SM, Hunt RC, Sullivent EE, et al. Guidelines for field triage of injured patients. Recommendations of the National Expert Panel on Field Triage. MMWR Recomm Rep 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/25\">",
"      Lerner EB, Schwartz RB, Coule PL, et al. Mass casualty triage: an evaluation of the data and development of a proposed national guideline. Disaster Med Public Health Prep 2008; 2 Suppl 1:S25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/26\">",
"      Lipsky AM, Gausche-Hill M, Henneman PL, et al. Prehospital hypotension is a predictor of the need for an emergent, therapeutic operation in trauma patients with normal systolic blood pressure in the emergency department. J Trauma 2006; 61:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/27\">",
"      Shapiro NI, Kociszewski C, Harrison T, et al. Isolated prehospital hypotension after traumatic injuries: a predictor of mortality? J Emerg Med 2003; 25:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/28\">",
"      Bruns B, Gentilello L, Elliott A, Shafi S. Prehospital hypotension redefined. J Trauma 2008; 65:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/29\">",
"      Lecky F, Bryden D, Little R, et al. Emergency intubation for acutely ill and injured patients. Cochrane Database Syst Rev 2008; :CD001429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/30\">",
"      Winchell RJ, Hoyt DB. Endotracheal intubation in the field improves survival in patients with severe head injury. Trauma Research and Education Foundation of San Diego. Arch Surg 1997; 132:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/31\">",
"      Copass MK, Oreskovich MR, Bladergroen MR, Carrico CJ. Prehospital cardiopulmonary resuscitation of the critically injured patient. Am J Surg 1984; 148:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/32\">",
"      Hedges JR, Feero S, Moore B, et al. Factors contributing to paramedic onscene time during evaluation and management of blunt trauma. Am J Emerg Med 1988; 6:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/33\">",
"      Eckstein M, Chan L, Schneir A, Palmer R. Effect of prehospital advanced life support on outcomes of major trauma patients. J Trauma 2000; 48:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/34\">",
"      Bernard SA. Paramedic intubation of patients with severe head injury: a review of current Australian practice and recommendations for change. Emerg Med Australas 2006; 18:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/35\">",
"      Sen A, Nichani R. Best evidence topic report. Prehospital endotracheal intubation in adult major trauma patients with head injury. Emerg Med J 2005; 22:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/36\">",
"      Davis DP, Peay J, Sise MJ, et al. The impact of prehospital endotracheal intubation on outcome in moderate to severe traumatic brain injury. J Trauma 2005; 58:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/37\">",
"      Ufberg JW, Bushra JS, Karras DJ, et al. Aspiration of gastric contents: association with prehospital intubation. Am J Emerg Med 2005; 23:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/38\">",
"      Stockinger ZT, McSwain NE Jr. Prehospital endotracheal intubation for trauma does not improve survival over bag-valve-mask ventilation. J Trauma 2004; 56:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/39\">",
"      Wang HE, Yealy DM. Out-of-hospital endotracheal intubation: where are we? Ann Emerg Med 2006; 47:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/40\">",
"      Wirtz DD, Ortiz C, Newman DH, Zhitomirsky I. Unrecognized misplacement of endotracheal tubes by ground prehospital providers. Prehosp Emerg Care 2007; 11:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/41\">",
"      Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban emergency medical services system. Ann Emerg Med 2001; 37:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/42\">",
"      Cobas MA, De la Pe&ntilde;a MA, Manning R, et al. Prehospital intubations and mortality: a level 1 trauma center perspective. Anesth Analg 2009; 109:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/43\">",
"      Wayne MA, Friedland E. Prehospital use of succinylcholine: a 20-year review. Prehosp Emerg Care 1999; 3:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/44\">",
"      Krisanda, T, Eitel, D, Cooley, M, et al. Succinylcholine assisted intubation by responding advanced life support ground units: results of a four year plus study for the state of Pennsylvania [abstract]. Acad Emerg Med 1997; 4:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/45\">",
"      Mizelle HL, Rothrock SG, Silvestri S, Pagane J. Preventable morbidity and mortality from prehospital paralytic assisted intubation: can we expect outcomes comparable to hospital-based practice? Prehosp Emerg Care 2002; 6:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/46\">",
"      Davis DP, Ochs M, Hoyt DB, et al. Paramedic-administered neuromuscular blockade improves prehospital intubation success in severely head-injured patients. J Trauma 2003; 55:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/47\">",
"      Ochs M, Davis D, Hoyt D, et al. Paramedic-performed rapid sequence intubation of patients with severe head injuries. Ann Emerg Med 2002; 40:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/48\">",
"      Davis DP, Hoyt DB, Ochs M, et al. The effect of paramedic rapid sequence intubation on outcome in patients with severe traumatic brain injury. J Trauma 2003; 54:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/49\">",
"      Bochicchio GV, Ilahi O, Joshi M, et al. Endotracheal intubation in the field does not improve outcome in trauma patients who present without an acutely lethal traumatic brain injury. J Trauma 2003; 54:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/50\">",
"      Murray JA, Demetriades D, Berne TV, et al. Prehospital intubation in patients with severe head injury. J Trauma 2000; 49:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/51\">",
"      Fakhry SM, Scanlon JM, Robinson L, et al. Prehospital rapid sequence intubation for head trauma: conditions for a successful program. J Trauma 2006; 60:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/52\">",
"      Bair AE, Smith D, Lichty L. Intubation confirmation techniques associated with unrecognized non-tracheal intubations by pre-hospital providers. J Emerg Med 2005; 28:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/53\">",
"      Timmermann A, Russo SG, Eich C, et al. The out-of-hospital esophageal and endobronchial intubations performed by emergency physicians. Anesth Analg 2007; 104:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/54\">",
"      Silvestri S, Ralls GA, Krauss B, et al. The effectiveness of out-of-hospital use of continuous end-tidal carbon dioxide monitoring on the rate of unrecognized misplaced intubation within a regional emergency medical services system. Ann Emerg Med 2005; 45:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/55\">",
"      Education of out-of-hospital emergency medical personnel in pediatrics: report of a National Task Force. Ann Emerg Med 1998; 31:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/56\">",
"      O'Connor RE, Slovis CM, Hunt RC, et al. Eliminating errors in emergency medical services: realities and recommendations. Prehosp Emerg Care 2002; 6:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/57\">",
"      National Association of EMS Physicians. Drug-assisted intubation in the prehospital setting position statement of the National Association of Emergency Physicians. Prehosp Emerg Care 2006; 10:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/58\">",
"      Konrad C, Sch&uuml;pfer G, Wietlisbach M, Gerber H. Learning manual skills in anesthesiology: Is there a recommended number of cases for anesthetic procedures? Anesth Analg 1998; 86:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/59\">",
"      Matt Ritter E, Bowyer MW. Simulation for trauma and combat casualty care. Minim Invasive Ther Allied Technol 2005; 14:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/60\">",
"      Barsuk D, Ziv A, Lin G, et al. Using advanced simulation for recognition and correction of gaps in airway and breathing management skills in prehospital trauma care. Anesth Analg 2005; 100:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/61\">",
"      Dorlac WC, DeBakey ME, Holcomb JB, et al. Mortality from isolated civilian penetrating extremity injury. J Trauma 2005; 59:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/62\">",
"      Beekley AC, Sebesta JA, Blackbourne LH, et al. Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes. J Trauma 2008; 64:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/63\">",
"      Kragh JF Jr, Walters TJ, Baer DG, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma 2008; 64:S38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/64\">",
"      Kragh JF Jr, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg 2009; 249:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/65\">",
"      Acheson EM, Kheirabadi BS, Deguzman R, et al. Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. J Trauma 2005; 59:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/66\">",
"      Cotton BA, Jerome R, Collier BR, et al. Guidelines for prehospital fluid resuscitation in the injured patient. J Trauma 2009; 67:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/67\">",
"      Frascone RJ, Jensen JP, Kaye K, Salzman JG. Consecutive field trials using two different intraosseous devices. Prehosp Emerg Care 2007; 11:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/68\">",
"      Glaeser PW, Hellmich TR, Szewczuga D, et al. Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med 1993; 22:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/69\">",
"      Schwartz D, Amir L, Dichter R, Figenberg Z. The use of a powered device for intraosseous drug and fluid administration in a national EMS: a 4-year experience. J Trauma 2008; 64:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/70\">",
"      Brown LH, Gough JE, Simonds WB. Can EMS providers adequately assess trauma patients for cervical spinal injury? Prehosp Emerg Care 1998; 2:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/71\">",
"      Meldon SW, Brant TA, Cydulka RK, et al. Out-of-hospital cervical spine clearance: agreement between emergency medical technicians and emergency physicians. J Trauma 1998; 45:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/72\">",
"      Domeier RM, Frederiksen SM, Welch K. Prospective performance assessment of an out-of-hospital protocol for selective spine immobilization using clinical spine clearance criteria. Ann Emerg Med 2005; 46:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/73\">",
"      Del Rossi G, Horodyski M, Conrad BP, et al. Transferring patients with thoracolumbar spinal instability: are there alternatives to the log roll maneuver? Spine (Phila Pa 1976) 2008; 33:1611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/74\">",
"      White LJ, Cooper JD, Chambers RM, Gradisek RE. Prehospital use of analgesia for suspected extremity fractures. Prehosp Emerg Care 2000; 4:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/75\">",
"      McEachin CC, McDermott JT, Swor R. Few emergency medical services patients with lower-extremity fractures receive prehospital analgesia. Prehosp Emerg Care 2002; 6:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/76\">",
"      Hennes H, Kim MK, Pirrallo RG. Prehospital pain management: a comparison of providers' perceptions and practices. Prehosp Emerg Care 2005; 9:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/77\">",
"      Abbuhl FB, Reed DB. Time to analgesia for patients with painful extremity injuries transported to the emergency department by ambulance. Prehosp Emerg Care 2003; 7:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/78\">",
"      Alonso-Serra HM, Wesley K, National Association of EMS Physicians Standards and Clinical Practices Committee. Prehospital pain management. Prehosp Emerg Care 2003; 7:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/79\">",
"      Garrick JF, Kidane S, Pointer JE, et al. Analysis of the paramedic administration of fentanyl. J Opioid Manag 2011; 7:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/80\">",
"      Soriya GC, McVaney KE, Liao MM, et al. Safety of prehospital intravenous fentanyl for adult trauma patients. J Trauma Acute Care Surg 2012; 72:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/81\">",
"      Thomas SH, Rago O, Harrison T, et al. Fentanyl trauma analgesia use in air medical scene transports. J Emerg Med 2005; 29:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/82\">",
"      Jennings PA, Cameron P, Bernard S, et al. Morphine and ketamine is superior to morphine alone for out-of-hospital trauma analgesia: a randomized controlled trial. Ann Emerg Med 2012; 59:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/83\">",
"      Marcolini EG, Burton JH, Bradshaw JR, Baumann MR. A standing-order protocol for cricothyrotomy in prehospital emergency patients. Prehosp Emerg Care 2004; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/84\">",
"      Holloway VJ, Harris JK. Spontaneous pneumothorax: is it under tension? J Accid Emerg Med 2000; 17:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/85\">",
"      Leigh-Smith S, Davies G. Tension pneumothorax: eyes may be more diagnostic than ears. Emerg Med J 2003; 20:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/86\">",
"      Hannum, J, Busko, JM, Dix, S, et al. Description of 33 prehospital needle chest decompressions for presumed tension pneumothorax [abstract]. Prehosp Emerg Care 2005; 9:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/87\">",
"      Cullinane DC, Morris JA Jr, Bass JG, Rutherford EJ. Needle thoracostomy may not be indicated in the trauma patient. Injury 2001; 32:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/88\">",
"      Eckstein M, Suyehara D. Needle thoracostomy in the prehospital setting. Prehosp Emerg Care 1998; 2:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/89\">",
"      Mines D, Abbuhl S. Needle thoracostomy fails to detect a fatal tension pneumothorax. Ann Emerg Med 1993; 22:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/90\">",
"      Wax DB, Leibowitz AB. Radiologic assessment of potential sites for needle decompression of a tension pneumothorax. Anesth Analg 2007; 105:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/91\">",
"      Zengerink I, Brink PR, Laupland KB, et al. Needle thoracostomy in the treatment of a tension pneumothorax in trauma patients: what size needle? J Trauma 2008; 64:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/92\">",
"      Givens ML, Ayotte K, Manifold C. Needle thoracostomy: implications of computed tomography chest wall thickness. Acad Emerg Med 2004; 11:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/93\">",
"      Stevens RL, Rochester AA, Busko J, et al. Needle thoracostomy for tension pneumothorax: failure predicted by chest computed tomography. Prehosp Emerg Care 2009; 13:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/94\">",
"      Inaba K, Ives C, McClure K, et al. Radiologic evaluation of alternative sites for needle decompression of tension pneumothorax. Arch Surg 2012; 147:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/95\">",
"      Branas CC, MacKenzie EJ, Williams JC, et al. Access to trauma centers in the United States. JAMA 2005; 293:2626.",
"     </a>",
"    </li>",
"    <li>",
"     Meier, B, Saul, S. Fatal crashes provoke debate on safety of sky ambulances. New York Times, February 28, 2005.",
"    </li>",
"    <li>",
"     Levin, A, Davis, R. Surge in crashes scars air ambulance industry. USA Today, July 18, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/98\">",
"      Isakov AP. Souls on board: helicopter emergency medical services and safety. Ann Emerg Med 2006; 47:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/99\">",
"      Baker SP, Grabowski JG, Dodd RS, et al. EMS helicopter crashes: what influences fatal outcome? Ann Emerg Med 2006; 47:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/100\">",
"      Haller JS Jr. The beginnings of urban ambulance service in the United States and England. J Emerg Med 1990; 8:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/4/17482/abstract/101\">",
"      HAMPTON OP Jr. Transportation of the injured, a report. Bull Am Coll Surg 1960; 45:55.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 347 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17482=[""].join("\n");
var outline_f17_4_17482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EMERGENCY MEDICAL SERVICE (EMS) SYSTEM DESIGN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREHOSPITAL TRAUMA CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Triage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Initial evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Secondary survey",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Airway support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Controversies and guidelines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Head injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Moving intubated patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Airway training for EMS providers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hemorrhage control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Intravenous (IV) fluids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Spinal immobilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27340367\">",
"      Pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SPECIALIZED PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Needle and surgical cricothyroidotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Needle chest decompression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SPECIAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Air medical services",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Burn management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Prehospital determination of death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2194152\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/347\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/347|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?22/18/22822\" title=\"algorithm 1\">",
"      US 2011 trauma field triage algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/347|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/28/17868\" title=\"table 1\">",
"      Triage scoring systems",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=related_link\">",
"      Carbon dioxide monitoring (capnography)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=related_link\">",
"      Direct laryngoscopy and tracheal intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=related_link\">",
"      Emergent surgical cricothyrotomy (cricothyroidotomy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=related_link\">",
"      Evaluation and acute management of cervical spinal column injuries in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=related_link\">",
"      Initial evaluation and management of shock in adult trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/3/16441?source=related_link\">",
"      Needle cricothyroidotomy with percutaneous transtracheal ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=related_link\">",
"      Pediatric cervical spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=related_link\">",
"      Pelvic trauma: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37479?source=related_link\">",
"      Treatment of minor thermal burns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_4_17483="Growth factors and stem cells";
var content_f17_4_17483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Action of hematopoietic growth factors on progenitor cells",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Lineage stem cell",
"       </td>",
"       <td class=\"subtitle1\">",
"        Required growth factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CFU-GEMM",
"       </td>",
"       <td>",
"        SCF + IL-3, IL-6, GM-CSF, EPO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        BFU-E",
"       </td>",
"       <td>",
"        SCF + IL-3, GM-CSF, EPO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CFU-GM",
"       </td>",
"       <td>",
"        SCF + G-CSF or M-CSF plus GM-CSF, IL-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CFU-G",
"       </td>",
"       <td>",
"        SCF + G-CSF plus GM-CSF, IL-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CFU-M",
"       </td>",
"       <td>",
"        SCF + M-CSF plus GM-CSF, IL-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CFU-Meg",
"       </td>",
"       <td>",
"        SCF + IL-3, IL-6, TPO",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CFU-GEMM: colony-forming unit - granulocytes, erythrocytes, monocytes and megakaryocytes; BFU-E: erythroid burst-forming unit; CFU-GM: granulocyte macrophage colony-forming unit; CFU-G: granulocyte colony-forming unit; CFU-M: monocyte colony-forming unit; CFU-Meg: megakaryocyte colony-forming unit; SCF: stem cell factor; IL-3: interleukin-3; IL-6: interleukin-6; GM-CSF: granulocyte-macrophage colony-stimulating factor; EPO: erythropoietin; G-CSF: granulocyte colony-stimulating factor; M-CSF: macrophage colony-stimulating factor; TPO: thrombopoietin.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17483=[""].join("\n");
var outline_f17_4_17483=null;
var title_f17_4_17484="SSRI-SNRI dosage PTSD";
var content_f17_4_17484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F55682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F55682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    SSRI and SNRI oral dosage (adult) for treatment of post-traumatic stress disorder (PTSD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Usual starting dose, mg",
"       </td>",
"       <td class=\"subtitle1\">",
"        Low starting dose, mg",
"       </td>",
"       <td class=\"subtitle1\">",
"        Therapeutic dose (daily), mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paroxetine",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        5 to 10",
"       </td>",
"       <td>",
"        20 to 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sertraline",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        12.5 to 25",
"       </td>",
"       <td>",
"        50 to 200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluvoxamine",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        100 to 300*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluoxetine",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        20 to 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Citalopram",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        20 to 40",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Escitalopram",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        20 to 30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Venlafaxine (extended-release)",
"       </td>",
"       <td>",
"        37.5",
"       </td>",
"       <td>",
"        37.5",
"       </td>",
"       <td>",
"        37.5 to 300",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SSRI: selective serotonin reuptake inhibitor; SNRI: serotonin norepinephrine reuptake inhibitor.",
"     <br>",
"      * If an immediate release preparation of fluvoxamine is used, dose shown in table should be given in two divided doses.",
"      <br>",
"       &bull; Maximum recommended dose of citalopram is 20 mg for patients &gt;60 years of age, with significant hepatic insufficiency, or taking interacting medications that can increase citalopram levels. See UpToDate topic: \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration and side effects\", sections \"Citalopram\" and \"Cardiac\".&nbsp; Specific interactions of citalopram with other medications may be determined using the drug interactions tool (Lexi-Interact Online) included in UpToDate. This tool can be accessed from the UpToDate online search page or through the individual drug information topics in the section on Drug interactions.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17484=[""].join("\n");
var outline_f17_4_17484=null;
var title_f17_4_17485="IV temsirolimus regimen";
var content_f17_4_17485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F68554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F68554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Temsirolimus for the initial treatment of poor-prognosis metastatic renal cell carcinoma",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: Weekly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Temsirolimus",
"        </strong>",
"       </td>",
"       <td>",
"        25 mg IV*",
"       </td>",
"       <td>",
"        Dilute in 250 mL normal saline (NS) and infuse via an infusion pump over 60 minutes for the first dose",
"        <sup>",
"         &Delta;",
"        </sup>",
"        . Subsequent doses may be given over 30 minutes if tolerated.",
"       </td>",
"       <td>",
"        Once weekly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        LOW (10 to 30 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Temsirolimus has caused hypersensitivity reactions, including anaphylaxis, which can occur with the initial as well as subsequent infusions. Premedication with an H1-antagonist such as diphenhydramine is recommended. Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Not applicable. Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver dysfunction:",
"        </strong>",
"        For patients with liver dysfunction (bilirubin &gt;1.5 to 1.5 times the upper limit of normal [ULN] or AST &gt;ULN with a normal bilirubin), the dose of temsirolimus should be reduced to 15 mg. Temsirolimus is contraindicated for bilirubin &gt;1.5 times the ULN",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Serum electrolytes at baseline then every two to four weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Serum glucose, cholesterol, and triglycerides at baseline then every four weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Temsirolimus should not be administered if the absolute neutrophil count (ANC) is &lt;1000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and/or platelet count is &lt;50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        . Withhold treatment until myelotoxicity resolves to grade 2 or less (ANC &gt;1000/mm",
"        <sup>",
"         3",
"        </sup>",
"        , platelets &gt;50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        ), then restart with a 5 mg per week dose reduction (minimum dose is 15 mg per week)",
"        <sup>",
"         [2]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; AST: aspartate aminotransferase; CBC: complete blood count.",
"     <br/>",
"     * Total dose, not adjusted for weight or body surface area.",
"     <br/>",
"     &Delta; Administer through an inline 5-micron (or smaller), polyethersulfone filter. Do not use DEHP-containing (PVC) containers or administration sets",
"     <sup>",
"      [2]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Hudes G, et al. N Engl J Med 2007; 356:2271.",
"      </li>",
"      <li>",
"       Torisel (temsirolimus) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 8, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17485=[""].join("\n");
var outline_f17_4_17485=null;
var title_f17_4_17486="Gram stain CSF 2 with answer";
var content_f17_4_17486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neisseria meningitidis in cerebrospinal fluid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of cerebrospinal fluid (x1000) shows inflammatory cells and kidney-shaped, gram-negative diplococci (arrows).",
"    <em>",
"     Neisseria meningitidis",
"    </em>",
"    grew from this specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17486=[""].join("\n");
var outline_f17_4_17486=null;
var title_f17_4_17487="Shave biopsy";
var content_f17_4_17487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Shave biopsy technique",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Half of a double-edge razor is curved with the thumb and forefinger to perform a shave biopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from Alguire, PC, Mathes, BM, J Gen Intern Med 1998; 13:46.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_4_17487=[""].join("\n");
var outline_f17_4_17487=null;
